0001075531-23-000065.txt : 20231213 0001075531-23-000065.hdr.sgml : 20231213 20231213091143 ACCESSION NUMBER: 0001075531-23-000065 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20231213 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231213 DATE AS OF CHANGE: 20231213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Booking Holdings Inc. CENTRAL INDEX KEY: 0001075531 STANDARD INDUSTRIAL CLASSIFICATION: TRANSPORTATION SERVICES [4700] IRS NUMBER: 061528493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36691 FILM NUMBER: 231483080 BUSINESS ADDRESS: STREET 1: 800 CONNECTICUT AVE CITY: NORWALK STATE: CT ZIP: 06854 BUSINESS PHONE: 203-299-8000 MAIL ADDRESS: STREET 1: 800 CONNECTICUT AVE CITY: NORWALK STATE: CT ZIP: 06854 FORMER COMPANY: FORMER CONFORMED NAME: Priceline Group Inc. DATE OF NAME CHANGE: 20140328 FORMER COMPANY: FORMER CONFORMED NAME: PRICELINE COM INC DATE OF NAME CHANGE: 19981221 8-K 1 bkng-20231213.htm 8-K bkng-20231213
false000107553100010755312023-12-132023-12-130001075531us-gaap:CommonStockMember2023-12-132023-12-130001075531bkng:A2.375SeniorNotesDueSeptember2024MemberMember2023-12-132023-12-130001075531bkng:A0100SeniorNotesDue2025Member2023-12-132023-12-130001075531bkng:A4000SeniorNotesDue2026Member2023-12-132023-12-130001075531bkng:A1.8SeniorNotesDueMarch2027Member2023-12-132023-12-130001075531bkng:A05SeniorNotesDueMarch2028Member2023-12-132023-12-130001075531bkng:A3625SeniorNotesDue2028Member2023-12-132023-12-130001075531bkng:A4250SeniorNotesDue2029Member2023-12-132023-12-130001075531bkng:A450SeniorNotesDue2031Member2023-12-132023-12-130001075531bkng:A4125SeniorNotesDue2033Member2023-12-132023-12-130001075531bkng:A4750SeniorNotesDue2034Member2023-12-132023-12-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) December 13, 2023
 
Booking Holdings Inc.
(Exact name of registrant as specified in its charter)
 
Delaware1-3669106-1528493
(State or other Jurisdiction of
Incorporation)
(Commission File Number)(IRS Employer Identification No.)
 
800 Connecticut AvenueNorwalkConnecticut06854
(Address of principal executive offices)(zip code)
 
Registrant's telephone number, including area code: (203) 299-8000

N/A 
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  Soliciting material pursuant to Rule 14a-12  under the Exchange Act (17 CFR 240.14a-12)
 
            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each Class: Trading SymbolName of Each Exchange on which Registered:
Common Stock par value $0.008 per share BKNGThe NASDAQ Global Select Market
2.375% Senior Notes Due 2024BKNG 24The NASDAQ Stock Market LLC
0.100% Senior Notes Due 2025BKNG 25The NASDAQ Stock Market LLC
4.000% Senior Notes Due 2026BKNG 26The NASDAQ Stock Market LLC
1.800% Senior Notes Due 2027BKNG 27The NASDAQ Stock Market LLC
0.500% Senior Notes Due 2028BKNG 28The NASDAQ Stock Market LLC
3.625% Senior Notes Due 2028BKNG 28AThe NASDAQ Stock Market LLC
4.250% Senior Notes Due 2029BKNG 29The NASDAQ Stock Market LLC
4.500% Senior Notes Due 2031BKNG 31The NASDAQ Stock Market LLC
4.125% Senior Notes Due 2033BKNG 33The NASDAQ Stock Market LLC
4.750% Senior Notes Due 2034BKNG 34The NASDAQ Stock Market LLC



 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 13, 2023, Booking Holdings Inc. (the "Company") announced that it has appointed Ewout L. Steenbergen as its Executive Vice President and Chief Financial Officer effective as of March 15, 2024. Mr. Steenbergen, age 54, has served as EVP, Chief Financial Officer at S&P Global Inc. ("S&P"), a financial information and analytics company, since 2016. Mr. Steenbergen was also appointed as President, Engineering Solutions in 2022 when S&P merged with IHS Markit, and led Kensho Technologies, an artificial intelligence company, since 2018. Prior to his role with S&P, Mr. Steenbergen served as Executive Vice President and CFO of Voya Financial, Inc., a financial services company. He also serves as Chair of the Board of Directors of UNICEF USA.

In connection with Mr. Steenbergen's appointment as the Company's Executive Vice President and Chief Financial Officer, he and the Company entered into an employment agreement (the "Employment Agreement") with, among others, the following terms:
an initial annual base salary of $825,000;
a target annual bonus of 180% of base salary, prorated for 2024;
a grant of restricted stock units ("New Hire RSUs") expected to be made on May 12, 2024 with a grant date fair value of $9,000,000 (or a pro rata cash amount in lieu of such award in the event of his termination without Cause or his resignation for Good Reason (each as defined in the Employment Agreement), death or disability before such grant is made);
a grant of restricted stock units ("RSUs") expected to be made on May 12, 2024 with a grant date fair value of $3,700,000;
a grant of performance share units ("PSUs") expected to be made on May 12, 2024 with a grant date fair value at target of $3,700,000;
a signing bonus of $1,000,000; and
in the event of his termination without Cause or his resignation for Good Reason, severance benefits including payments equal to one times his base salary and target annual bonus (two times if the termination occurs within 12 months after a Change of Control (as defined in the Employment Agreement) or, under certain circumstances, within 6 months prior to a Change of Control), a prorated portion of any earned bonus for the year of termination, health benefits for a period of 12 months, and any earned bonus for a prior completed year that has not yet been paid.

Mr. Steenbergen's New Hire RSUs will vest 75% on the first anniversary of the grant date and 25% on the second anniversary of the grant date, and his RSUs will vest in three equal annual installments on each of the first three anniversaries of the grant date, in each case subject to his continuous service from the date of grant until the applicable vesting date. Mr. Steenbergen's PSUs will vest upon completion of three years of continuous service from the date of grant and achievement of the applicable performance metrics. The New Hire RSUs, RSUs, and PSUs are each subject to pro rata vesting upon Mr. Steenbergen's termination without Cause or on account of disability or his resignation for Good Reason, or full vesting upon death. The awards will be subject to the other terms of the respective award agreements, which are expected to be substantially similar to the Form of Restricted Stock Unit Agreement and the Form of Performance Share Unit Agreement for awards under the 1999 Omnibus Plan, respectively. Grant date fair values are determined in accordance with the Company's 1999 Omnibus Plan and its standard grant practices.

The summaries of the Employment Agreement, Form of Performance Share Unit Agreement under the 1999 Omnibus Plan, and Form of Restricted Stock Unit Agreement under the 1999 Omnibus Plan are qualified in their entirety by reference to the agreements themselves, which are attached to this Current Report as Exhibits 99.1, 99.2, and 99.3, respectively, and which are incorporated by reference into this Item 5.02.

In connection with Mr. Steenbergen's appointment, the Company and Mr. Steenbergen have also entered into a Non-Competition and Non-Solicitation Agreement and an Employee Confidentiality and Assignment Agreement, copies of which are attached to this Current Report as Exhibits 99.4 and 99.5, respectively, and which are incorporated by reference into this Item 5.02.

As previously reported by the Company in its Current Report on Form 8-K filed with the Commission on February 23, 2023 (the "Prior 8-K"), upon commencement of employment by Mr. Steenbergen, Mr. Goulden will no longer serve as the Company's Chief Financial Officer. For more information on Mr. Goulden's role with the Company, see the Prior 8-K.

Item 7.01.     Regulation FD Disclosure.




A copy of the press release announcing the appointment of Mr. Steenbergen referenced in Item 5.02 is furnished with this Current Report as Exhibit 99.6.

The information furnished pursuant to this Item 7.01 of this Current Report shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.           Financial Statements and Exhibits.
 
(d)    Exhibits
Exhibit
Number
Description
Employment Agreement, dated December 4, 2023, by and between the Company and Ewout L. Steenbergen.
99.2(a)
Form of Performance Share Unit Agreement under the Company's 1999 Omnibus Plan.
Form of Restricted Stock Unit Agreement under the Company's 1999 Omnibus Plan.
Non-Competition and Non-Solicitation Agreement, dated December 4, 2023, by and between the Company and Ewout L. Steenbergen.
Employee Confidentiality and Assignment Agreement, dated December 4, 2023, by and between the Company and Ewout L. Steenbergen.
Press Release, dated December 13, 2023.
104Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
(a)     Previously filed as an exhibit to the Current Report on Form 8-K filed on February 23, 2023 and incorporated by reference.





SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 BOOKING HOLDINGS INC.
  
   
 By:/s/ Peter J. Millones
  Name:Peter J. Millones
  Title:Executive Vice President and General Counsel
 
 
Date:  December 13, 2023


EX-99.1 2 exhibit991es.htm EX-99.1 Document
EXHIBIT 99.1

December 1, 2023
Ewout Steenbergen
Re: Employment Agreement
Dear Ewout:
This letter agreement (this “Agreement”) sets forth the terms and conditions of your employment as Executive Vice President and Chief Financial Officer of Booking Holdings Inc., a Delaware corporation with its principal United States office at 800 Connecticut Avenue, Norwalk, Connecticut 06854 (the “Company”), effective as of a date between December 4, 2023 and March 31, 2024 (inclusive) to be mutually agreed upon between you and the Company (the “Effective Date”) and documented via an addendum to this Agreement. In consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, you and the Company agree as follows:
1.Your Term and Location of Employment. Except for earlier termination as provided in Section 7 hereof, your employment with the Company will be for three (3) years beginning on the Effective Date and ending on the day before the third (3rd) anniversary of the Effective Date (the “Initial Employment Term”). Your employment will be automatically extended for additional terms of successive one (1) year periods (each, an “Additional Employment Term”) unless the Company or you gives written notice to the other at least ninety (90) days prior to the expiration of the Initial Employment Term or then-current Additional Employment Term that the term of your employment under this Agreement will not be extended. The Initial Employment Term and each Additional Employment Term are referred to as the “Employment Term.” Your principal place of employment will be at the Company’s principal United States office in Norwalk, Connecticut. You may be permitted to work remotely subject to Company policies, rules, or guidance in place from time to time, and provided that any such remote work does not interfere with your ability to perform your duties under this Agreement, as determined by the Chief Executive Officer in his sole discretion.
2.Your Positions and Duties. Beginning on the Effective Date, you will serve as an Executive Vice President and the Chief Financial Officer of the Company.
(a)You will report directly to the Chief Executive Officer of the Company (the “Chief Executive Officer”). You will have duties and authority consistent with the positions of Executive Vice President and Chief Financial Officer and such other duties reasonably consistent with your role as a senior executive of the Company as the Chief Executive Officer or the Board of Directors of the Company (the “Board”) may assign to you from time to time.
(b)During the Employment Term, you will devote substantially all of your business time and efforts to the performance of your duties under this Agreement; provided, however, that you will be allowed, to the extent that such activities do not materially interfere with the performance of your duties and responsibilities, to serve on corporate, civic, charitable
1



and industry boards or committees. Notwithstanding the foregoing, during the Employment Term, you will not serve on the board of directors, board of trustees or any similar governing body of any for-profit entity unless approved in advance in writing by the Chief Executive Officer.
3.Base Salary. During the Employment Term, your base salary will be at an annual rate of not less than $825,000 and will be payable in accordance with the usual payroll practices of the Company. Your base salary will be subject to annual review by the Board or the Talent and Compensation Committee of the Board (the “Compensation Committee”) and may be increased from time to time by the Board or the Compensation Committee, but not decreased, unless the Board or the Compensation Committee reduces the base salary in a proportionate amount for all executive officers of the Company (as determined from time to time, your “Base Salary”). Following the Effective Date, the next review of your Base Salary would be effective March 1, 2025.
4.Incentive Compensation.
(a)Discretionary Bonus. Starting in 2024, for each fiscal year during the Employment Term, you will be eligible to participate in any annual bonus plan the Company may implement for senior executives of the Company. Your target annual bonus (“Annual Bonus”) for 2024 and subsequent years during the Employment Term will be equal to 180% of your Base Salary and will be payable in cash in accordance with the terms of the Company’s annual bonus plan; provided, however, in 2024, such target Annual Bonus will be multiplied by (ii) a fraction, the numerator of which is the number of days in 2024 during which you were employed by the Company, and the denominator of which is 366. As all bonuses are discretionary, you acknowledge that you do not earn an entitlement to a bonus, or any portion thereof, by working or continuing employment, and you may not earn or be awarded any bonus at all for some or all years, and there is no formula or guaranteed amount of any bonus that you will receive if a bonus is awarded to you or other executives of the Company. You will not be eligible to earn any bonus award in respect of the year in which your employment with the Company is terminated, or any subsequent year, except as specifically provided for in Section 8. Bonus awards do not accrue and are only earned and payable at the time of payment. You agree that this provision is meant to eliminate any legal right you may have to a bonus, or pro-rated bonus, in the event of resignation or termination, or any right you may have to a bonus payment as part of any damage award under the law.
(b)Long Term Compensation. For each fiscal year during the Employment Term, you will be eligible to participate in any long-term incentive compensation plan generally made available to senior executives of the Company.
(i)Subject to your continued employment with the Company, you will be granted a target number of performance share units (the “2024 PSUs”) on the Company’s first established quarterly grant date that occurs immediately following the Effective Date (the “Grant Date”), which number will be equal to the quotient of
2



$3,700,000 divided by the “Fair Market Value” per share of the Company’s common stock as determined under the Company’s 1999 Omnibus Plan, as amended from time to time (the “1999 Omnibus Plan”), on the Grant Date. The 2024 PSUs will have other terms generally consistent with those applicable to grants to other senior executives of the Company.
(ii)Subject to your continued employment with the Company, you will be granted a number of restricted stock units (the “2024 RSUs”) on the Grant Date, which number will be equal to the quotient of $3,700,000 divided by the “Fair Market Value” per share of the Company’s common stock as determined under the Company’s 1999 Omnibus Plan on the Grant Date. One third (1/3rd) of the 2024 RSUs will vest on each anniversary of the Grant Date, such that the 2024 RSUs will be 100% vested on the third anniversary of the Grant Date, subject to your continued employment through each such vesting date. The 2024 RSUs will have other terms generally consistent with those applicable to grants to other senior executives of the Company.
(iii)In subsequent years during the Employment Term, the amount and terms of any long-term incentive grants will be determined by the Compensation Committee in its sole discretion, provided that the target number of any equity awards granted to you under any long-term incentive compensation plan will be in an amount that is substantially consistent with those awards granted to other senior executives of the Company (other than the Chief Executive Officer).
(c)New Hire Grant. Subject to your continued employment with the Company, you will be granted a number of restricted stock units (the “New Hire RSUs”) on the Grant Date, which number will be equal to the quotient of $9,000,000 divided by the “Fair Market Value” per share of the Company’s common stock as determined under the 1999 Omnibus Plan on the Grant Date. 75% of the New Hire RSUs will vest on the first anniversary of the Grant Date and the remaining 25% of the New Hire RSUs will vest on the second anniversary of the Grant Date, subject to your continued employment through each such vesting date, and will otherwise be governed by the terms set forth in an award agreement under the 1999 Omnibus Plan. In the event that, prior to the Grant Date of the New Hire RSUs, your employment is terminated by the Company without Cause, by you for Good Reason, or as a result of your Disability or death, then in lieu of the New Hire RSUs, you (or, as applicable, your estate) will be entitled to receive a lump sum cash payment in an amount equal to $6,750,000 multiplied by a fraction, the numerator of which is the number of days that have elapsed during the period commencing on the Effective Date and ending on the date of your termination of employment and the denominator of which is 365, payable within sixty (60) days after the date of your employment termination. Except in the case of your death, your right to receive such payment in lieu of the New Hire RSUs is subject to your compliance with the Ancillary Agreements (as defined in section 11) and your execution on or after the date of
3



termination of a Release (as defined in section 8(c)), that becomes effective within 55 days after the date of termination.
(d)Signing Bonus. Within thirty (30) days following the Effective Date, the Company will make a lump sum payment to you in an amount equal to $1,000,000 (the “Signing Bonus”). The Signing Bonus is paid as an advance in recognition of your anticipated service to the Company. One twelfth (1/12) of the Signing Bonus is earned for each completed month of employment in the first twelve (12) months of employment, with the Signing Bonus becoming fully earned upon completion of your twelfth (12th) month of employment. If you resign from your employment without Good Reason, or if the Company terminates your employment for Cause, in either case before the first (1st) anniversary of the Effective Date, you will promptly repay the Company the gross unearned portion of the Signing Bonus. You agree to sign all documents necessary to facilitate the Company's recovery of this amount through payroll deductions or other means.
5.Employee Benefits and Vacation.
(a)During the Employment Term, you will be entitled to participate in benefit plans and arrangements and fringe benefits and perquisite programs no less favorable than those provided to other similarly-situated senior executives of the Company.
(b)During the Employment Term, you will be entitled to vacation each year in accordance with the Company’s policies in effect from time to time, but in no event less than 28 days of paid vacation per calendar year. You will also be entitled to such periods of sick leave as is customarily provided by the Company for its senior executive employees.
6.Business Expenses. The Company will reimburse you for the travel, entertainment, and other business expenses you incur in the performance of your duties, in accordance with the Company’s policies as in effect from time to time; providedhowever, that such expenses must be paid no later than the last day of the calendar year following the calendar year in which such expenses were incurred and further provided that in no event will the amount of expenses so reimbursed in one taxable year affect the amount of expenses eligible for reimbursement in any other taxable year.
7.Termination.
(a)Your employment under this Agreement will terminate upon the earliest to occur of any of the following events:
(i)the termination of your employment by the Company due to your Disability pursuant to Section 7(b);
(ii)your resignation for Good Reason pursuant to Section 7(c);
(iii)the termination of your employment by the Company without Cause;
4



(iv)your resignation without Good Reason upon sixty (60) days’ prior written notice;
(v)the termination of your employment by the Company for Cause pursuant to Section 7(d); or
(vi)your death.
Effective as of the date of any termination of your employment for any reason, you hereby agree to tender your resignation from, will be deemed to have automatically resigned from, all offices and directorships you hold at the Company and any of its Affiliates (as defined in the 1999 Omnibus Plan) at the date of such termination, including, without limitation, the position of Executive Vice President and Chief Financial Officer.

(b)Termination Due to Disability. If, by reason of the same or related physical or mental illness or incapacity, you are unable to carry out your material duties pursuant to this Agreement for more than six (6) consecutive months, the Company may terminate your employment for disability (“Disability”) after providing you with thirty (30) days’ written notice. A termination due to Disability will not be effective if you return to the full-time performance of your material duties within such thirty (30) day notice period.
(c)Termination for Good Reason. A termination for Good Reason means a termination of your employment by you following written Notice of Termination for Good Reason given by you to the Company pursuant to Section 7(c)(ii).
(i)    For purposes of this Agreement, “Good Reason” means the occurrence, without your prior written consent, of any of the following: (A) a material diminution in your authority, duties, title, reporting structure, or responsibilities (which shall not in any circumstance include the designation of a different person to serve as the Company’s chief accounting officer); (B) a relocation of the Company’s principal office in Norwalk, Connecticut to a location more than thirty-five (35) miles from its current location or more than thirty-five (35) miles further from your residence at the time of such relocation (provided you are required by the Company to work regularly from such principal office location); and (C) any material breach by the Company of this Agreement.

(ii)    For purposes of this Agreement, a “Notice of Termination for Good Reason” means a notice indicating the specific termination provision in Section 7(c)(i) relied upon and setting forth in reasonable detail the facts and circumstances claimed to provide a basis for the termination for Good Reason. Before a termination by you will constitute termination for Good Reason, you must give the Company a Notice of Termination for Good Reason within ninety (90) days following the occurrence of the event that constitutes Good Reason. Failure to provide such Notice of Termination for Good Reason within such ninety (90)-day period shall be conclusive proof that you shall not have Good Reason to terminate employment. Good Reason shall exist only if (A) the Company fails
5



to remedy the event or events constituting Good Reason within thirty (30) days after receipt of the Notice of Termination for Good Reason from you and (B) you terminate your employment within sixty (60) days after the end of the period set forth in clause (A) above. The Company’s placing you on paid leave (with full compensation and benefits for the portion of such period that occurs prior to your termination date) for up to sixty (60) consecutive days while it is determining whether there is a basis to terminate your employment for Cause will not constitute Good Reason.
(d)Cause. Subject to Section 7(d)(ii), your employment hereunder may be terminated by the Company for Cause.
(i)For purposes of this Agreement, the term “Cause” means (i) your willful and continued failure substantially to perform your duties and obligations to the Company (other than any such failure resulting from incapacity due to physical or mental illness); (ii) your willful engagement in misconduct which is materially injurious to the Company; (iii) your commission of a felony; (iv) your willful and material violation of any Company code of conduct; (v) your commission of a crime against the Company which is materially injurious to the Company; (vi) your material breach of any non-competition, non-solicitation, or other restrictive covenant that you enter into with the Company or a subsidiary; (vii) your willful and material breach of any confidentiality agreement that you enter into with the Company or a subsidiary; or (viii) the failure of any of your representations in Section 17 to have been true and correct. For purposes of this paragraph, no act, or failure to act, on your part will be considered “willful” unless done or omitted to be done, by you not in good faith and without reasonable belief that your action or omission was in the best interests of the Company. The Compensation Committee (or its delegate) will determine whether “Cause” exists in its sole discretion
(ii)For purposes of this Agreement, a “Notice of Termination for Cause” means a notice indicating the specific termination provision in Section 7(d)(i) relied upon and setting forth in reasonable detail the facts and circumstances which provide a basis for termination for Cause. Further, a Notice of Termination for Cause will be required to include a copy of a resolution duly adopted by at least a majority of the entire membership of the Board at a meeting of the Board which was called for the purpose of considering such termination and which you and your representative had the right to attend and address the Board, indicating that the Board had found, in good faith, that you had engaged in conduct set forth in the definition of Cause and specifying the particulars in reasonable detail. The date of termination for a termination for Cause will be the date indicated in the Notice of Termination for Cause. Any purported termination for Cause which is held by a court not to have been based on the grounds set forth in this Agreement or not to have followed the procedures set forth in this Agreement will be deemed a termination by the Company without Cause. Notwithstanding anything to the contrary in any equity
6



award or other agreement between you and the Company, the determination of “Cause” under such agreement will be determined by the Board in accordance with this Section 7(d)(ii).
8.Consequences of Termination of Employment.
(a)Death. If your employment is terminated by reason of your death, the Employment Term will terminate without further obligations to your legal representatives under this Agreement except for: (i) any compensation earned but not yet paid as of the date of your death, including, without limitation, any amount of Base Salary earned but unpaid, any accrued vacation pay payable pursuant to the Company’s policies, and any unreimbursed business expenses payable pursuant to Section 6 (collectively “Accrued Amounts”), which amounts will be promptly paid in a lump sum to your estate; (ii) any Annual Bonus for the fiscal year prior to the year in which your death occurs that has not been paid by the date of your death (a “Prior Year Bonus”), which Prior Year Bonus will be paid in a lump sum when bonuses for such period are paid to the Company’s other executive officers, but, in any event, no later than March 15 of the year of your death; (iii) any other amounts or benefits owing to you under the then applicable employee benefit plans, long-term incentive plans or equity plans and programs of the Company which will be paid or treated in accordance with the terms of such plans and programs; (iv) continuation, for twelve (12) months following the date of death, of your health benefits for your dependents at the same level and cost as if you were an employee of the Company, subject to the terms set forth in Section 8(e); and (v) if a bonus plan is in place, the product of (x) the target Annual Bonus for the fiscal year in which your death occurs, multiplied by (y) a fraction, the numerator of which is the number of days of the current fiscal year during which you were employed by the Company, and the denominator of which is 365 (or 366 in a leap year), which Annual Bonus will be paid in a lump sum when bonuses for such period are paid to the Company’s other executive officers, but, in any event, no later than March 15 of the fiscal year following the fiscal year to which such bonus relates.
(b)Disability. Subject to Section 8(g), if your employment is terminated by reason of your Disability, you will be entitled to receive the payments and benefits to which your representatives would be entitled in the event of a termination of employment by reason of your death, plus you will be entitled to continuation, for twelve (12) months following such termination of employment, of group life and disability insurance benefits as if you were an active employee of the Company.
(c)Termination by You for Good Reason, Termination by the Company without Cause during the Employment Term or Termination of this Agreement as a Result of a Notice of Non-Renewal by the Company. Subject to Section 8(g) and Section 9, if you terminate your employment under this Agreement for Good Reason, your employment is terminated by the Company without Cause, in each case during the Employment Term, or your employment is terminated as a result of your receipt of a notice from the Company, as
7



described in Section 1 hereof, of the Company’s decision not to extend the Employment Term, then you will be entitled to receive: (i) any Accrued Amounts at the date of termination, which amounts will be promptly paid in a lump sum; (ii) any Prior Year Bonus, which will be paid in a lump sum when bonuses for such period are paid to the Company’s other executive officers, but, in any event, no later than March 15 of the year of your termination; (iii) an amount equal to one (1) times the sum of your Base Salary and target Annual Bonus, if any, for the year in which such termination occurs, paid in equal installments over a period of twelve (12) months after the date of termination in accordance with the Company’s regular payroll practices, commencing no later than sixty (60) days after the date of your employment termination (providedhowever, if the Base Salary or target Annual Bonus, if any, has been decreased in the twelve (12) months before the termination, the amount to be used will be the highest Base Salary and target Annual Bonus, if any, during such twelve (12) month period); (iv) any other amounts or benefits owing to you under the then applicable employee benefit, long-term incentive or equity plans and programs of the Company, which will be paid or treated in accordance with the terms of such plans and programs; (v) continuation of group health benefits for a period of twelve (12) months as if you were an employee of the Company, subject to the terms set forth in Section 8(e); and (vi) if a bonus plan is in place, the product of (x) the actual Annual Bonus you would have earned for the fiscal year of your termination, and (y) a fraction, the numerator of which is the number of days of the current fiscal year during which you were employed by the Company, and the denominator of which is 365 (or 366 in a leap year), which prorated Annual Bonus will be paid in a lump sum when bonuses for such period are paid to the Company’s other executive officers, but, in any event, no later than March 15 of the fiscal year following the fiscal year to which such Annual Bonus relates. Your receipt of the payments and benefits described in this Section 8(c) (other than the Accrued Amounts) is conditioned on and subject to your compliance with the Ancillary Agreements (as defined in section 11) and your execution on or after the date of termination of a release of claims in favor of the Company, substantially in the form attached as Appendix A to this Agreement (the “Release”), that becomes effective within 55 days after the date of termination.
(d)Termination by You for Good Reason or Termination by the Company without Cause within 6 months preceding or 12 months following a Change in Control. Subject to Section 8(g) and Section 9, if you terminate your employment under this Agreement for Good Reason or your employment is terminated by the Company without Cause (i) within six (6) months preceding a Change in Control (and such termination of employment, or the event giving rise to your termination of employment for Good Reason, occurred at the request of a third party who had indicated an intention or taken steps reasonably calculated to effect a Change in Control, or at the request of any other person in anticipation of a Change in Control, and in either case, such Change in Control actually occurs) or (ii) within twelve (12) months after a Change in Control, then in lieu of any amounts or benefits payable under Section 8(c) above, you will be entitled to receive: (A) any Accrued Amounts at the date of termination, which amounts will be
8



promptly paid in a lump sum; (B) any Prior Year Bonus, which will be paid in a lump sum when bonuses for such period are paid to the Company’s other executive officers and by March 15th of the year of your termination; (C) an amount equal to two (2) times the sum of your Base Salary and target Annual Bonus, if any, for the year in which such termination occurs, paid in equal installments over a period of twenty-four (24) months after the date of termination in accordance with the Company’s regular payroll practices, commencing no later than sixty (60) days after the date of your employment termination (providedhowever, if the Base Salary or target Annual Bonus, if any, has been decreased in the twelve (12) months before the termination, the amount to be used will be the highest Base Salary and target Annual Bonus, if any, during such twelve (12) month period); (D) any other amounts or benefits owing to you under the then applicable employee benefit, long-term incentive or equity plans and programs of the Company, which will be paid or treated in accordance with the terms of such plans and programs and this Agreement; (E) continuation of group health benefits for a period of twelve (12) months as if you were an employee of the Company, subject to the terms set forth in Section 8(e); and (F) if a bonus plan is in place, the product of (x) the actual Annual Bonus you would have earned for the fiscal year of your termination, and (y) a fraction, the numerator of which is the number of days of the current fiscal year during which you were employed by the Company, and the denominator of which is 365 (or 366 in a leap year), which prorated Annual Bonus will be paid in a lump sum when bonuses for such period are paid to the Company’s other senior executive officers, but, in any event, no later than March 15 of the fiscal year following the fiscal year to which such Annual Bonus relates. Your receipt of the payments and benefits described in this Section 8(d) (other than the Accrued Amounts) is conditioned on and subject to your compliance with the Ancillary Agreements and your execution on or after the date of the Release, that becomes effective within 55 days after the date of termination.
(e)Continuation of Group Health Benefits. With respect to any continuation of group health benefits to you or your dependents in connection with your termination of employment pursuant to Section 8 of this Agreement, you will pay the full cost for such group health coverage on an after-tax basis for each month that you elect to retain such coverage by payment of the monthly cost of such coverage as determined for purposes of health care continuation under Section 4980B of the Internal Revenue Code of 1986, as amended (the “COBRA Premium”). Within five (5) business days after the date of the effectiveness of the Release, the Company will make a payment to you equal to the number of full and partial months remaining in the calendar year in which your employment is terminated, multiplied by the difference between the COBRA Premium for such year and the monthly amount that you were required to pay for group health coverage immediately prior to your termination of employment. On each January 2 thereafter until the end of the twelve (12) month period, as applicable, if you have maintained group health coverage through the last day of the preceding calendar year, the Company will make a payment to you equal to the difference between the COBRA Premium and the monthly amount that you were required to pay for group health coverage immediately prior to the termination of your
9



employment, multiplied by twelve (12), or, if the period of coverage is for less than a year, by the number of full and partial months remaining in the year until the end of the twelve (12) month period. Notwithstanding the foregoing, the period of coverage following the date of your termination of employment will be considered to be the period during which you will be eligible for continuation coverage under Section 4980B of the Internal Revenue Code of 1986, as amended (the “Code”). If this Agreement to provide group health benefits continuation results in any non-compliance with or impositions of penalties under the Patient Protection and Affordable Care Act or other applicable law, then the parties agree to modify this Agreement so that it complies with the terms of such laws.
(f)Termination for Cause, Voluntary Resignation without Good Reason or Termination of this Agreement as a Result of a Notice of Non-Renewal by You. If your employment hereunder is terminated (i) by the Company for Cause, (ii) by you without Good Reason, or (iii) your employment is terminated as a result of the Company’s receipt of a notice from you, as described in Section 1 hereof, of your decision not to extend the Employment Term, you will be entitled to receive only any Accrued Amounts at the date of termination. Your rights to any additional payments and benefits under all Company benefits plans, programs, and equity grants will be determined in accordance with such plans, programs, and grants.
(g)Separation from Service. Notwithstanding anything in this Agreement to the contrary, if you are a “specified employee” (within the meaning of Section 409A of the Code) and any payment made pursuant to this Agreement is considered to be a “deferral of compensation” (as such phrase is defined for purposes of Section 409A of the Code) that is payable upon your “separation from service” (within the meaning of Section 409A of the Code), then the payment date for such payment will be the date that is the first (1st) day of the seventh (7th) month after the date of your “separation from service” with the Company (determined in accordance with Section 409A of the Code) or your earlier death. In addition, if the event triggering your right to benefits or payments hereunder is your termination of employment, but such termination of employment does not constitute a “separation from service” with the Company within the meaning of Section 409A of the Code, then the benefits or payments hereunder payable by reason of such termination of employment that are considered to be a “deferral of compensation” under Section 409A of the Code will not be paid upon such termination of employment, but instead, will remain an obligation of the Company to you and will be paid or provided to you upon the first to occur of: (i) your “separation from service” (within the meaning of Section 409A of the Code) (any amount payable upon such “separation from service” being subject to the first sentence of this Section 8(g)); (ii) a “change of control” of the Company (within the meaning of Section 409A of the Code); or (iii) your death.
9.No Mitigation; No Set-Off. In the event of any termination of your employment hereunder, you will be under no obligation to seek other employment and there will be no offset against any amounts due to you under this Agreement on account of any remuneration attributable to any
10



subsequent employment that you may obtain. Notwithstanding the foregoing, in the event that your employment is terminated by the Company without Cause or by you for Good Reason, in either case within the first six (6) months of the Initial Employment Term, and after your date of termination, you directly or indirectly, without the prior written consent of the Company, engage in any of the same or substantially similar activities, duties, or responsibilities that you had while an employee of the Company, for any other company or business that competes with the Company, then to the fullest extent permitted by applicable law you will cease to be eligible to receive any benefits or amounts otherwise payable under Section 8(c) or Section 8(d) that are unpaid or outstanding as of the date you are first employed or engaged by such competing company or business, provided in any event that you will receive at least $100 as consideration for your Release.
10.Change in Control. For purposes of this Agreement, the term “Change in Control” has the meaning as set forth in the 1999 Omnibus Plan or its successor.
11.Ancillary Agreements; Acknowledgments. In connection with the execution of this Agreement, you agree to concurrently execute (a) the Non-Competition and Non-Solicitation Agreement (the “Non-Competition Agreement”) and the Employee Confidentiality and Assignment Agreement (the “Confidentiality and Assignment Agreement”), which are attached as Appendix B and Appendix C respectively, are each incorporated by reference into this Agreement and are together referred to as the “Ancillary Agreements;” and (b) acknowledgments of each of the Incentive-Based Compensation Clawback Policy and the Financial Restatement Recovery Policy, which are attached as Appendix D, and Appendix E respectively, and are together referred to as the “Clawback Policy Acknowledgments.”
12.Indemnification. The Company will indemnify you and hold you harmless to the fullest extent permitted by law for any action or inaction by you while serving as an officer of the Company or, at the Company’s request, as an officer or director of any other entity or as a fiduciary of any benefit plan. The Company will cover you under directors’ and officers’ liability insurance both during and, while potential liability exists, after the Employment Term in the same amount and to the same extent as the Company covers its other officers and directors.
13.Duty to Cooperate. You agree, after the termination of your employment, to reasonably cooperate with the Company and its Affiliates and their respective directors, officers, attorneys, and experts in all matters relating to your pending work on behalf of the Company and the orderly transfer of such pending work to other employees of the Company as may be designated by the Company. You further agree that you will cooperate in any legal disputes, proceedings or business matters relating to issues or incidents which took place during the term of your employment. Such cooperation may include appearances in court or discovery proceedings. Your reasonable and pre-approved out-of-pocket expenses incurred in connection therewith shall be reimbursed by the Company. Such expenses, however, will not include reimbursement for lost wages or attorneys’ fees and costs, unless such attorneys’ fees and costs are otherwise covered under the indemnification provisions of Section 12 hereof or under any other indemnification coverage to which you may be entitled as a result of your role on behalf of the Company. The
11



Company will provide you with reasonable notice whenever possible of the need for your cooperation.
14.Legal Fees. Subject to your continued employment as of the payment date, the Company will pay your reasonable legal fees and costs associated with entering into this Agreement, not to exceed $10,000. All payments by the Company of the legal fees to you under this Section 14 (or to the extent applicable, Section 15(a) below) will be for expenses incurred during your lifetime and will be made within ninety (90) days after the date you submit evidence of such expenses, and in all events prior to the last day of the calendar year following the calendar year in which you incur the expense. In no event will the amount of expenses reimbursed or paid in one year affect the amount of expenses eligible for reimbursement, or payment to, or for you in any other taxable year.
15.Disputes.
(a)All disputes and controversies arising under or in connection with this Agreement, other than the seeking of injunctive or other equitable relief pursuant to the Non-Competition Agreement or the Confidentiality and Assignment Agreement, will be settled by arbitration conducted before a panel of three (3) arbitrators sitting in Fairfield County, Connecticut, or such other location agreed by the parties hereto, in accordance with the rules for expedited resolution of commercial disputes of the American Arbitration Association then in effect. The determination of the majority of the arbitrators will be final and binding on the parties. Judgment may be entered on the award of the arbitrator in any court having proper jurisdiction. The Company will promptly pay all expenses of such arbitration, including the fees and expenses of your counsel. If the arbitrators determine that your position was overall frivolous or otherwise taken in bad faith, the arbitrators may determine that you be required to reimburse the Company for your own legal fees.
(b)In the event that after a Change in Control either party files for arbitration to resolve any dispute as to whether a termination is for Cause or Good Reason, until such dispute is determined by the arbitrators, you will continue to be treated economically and in respect of employee benefits in the manner asserted by you in the arbitration effective as of the date of the filing of the arbitration, subject to you promptly refunding any amounts paid to you, paying the cost of any benefits provided to you and paying to the Company the profits in any stock option or other equity awards exercised or otherwise realized by you during the pendency of the arbitration which you are ultimately held not to be entitled to; provided, that the arbitrators may terminate such payments and benefits in the event that they determine at any point that you are intentionally delaying conclusion of the arbitration.
16.Certain Adjustments by the Company. Notwithstanding any provision of this Agreement to the contrary, if any payment or benefit to be paid or provided to you, under this Agreement or any other arrangement (collectively, the “Total Payments”), would be a “Parachute Payment,” within the meaning of Section 280G of the Code, but for the application of this sentence, then the Total
12



Payments will be reduced to the minimum extent necessary (but in no event to less than zero) so that no portion of any such payment or benefit, as so reduced, constitutes a Parachute Payment; providedhowever, that the foregoing reduction will be made only if and to the extent that such reduction would result in an increase in the aggregate payments and benefits to be provided to you, determined on an after-tax basis (taking into account the excise tax imposed pursuant to Section 4999 of the Code, or any successor provision thereto, any tax imposed by any comparable provision of state law, and any applicable federal, state, and local income taxes). Any determinations required to be made under this Section 16 will be made by the Company’s independent accountants or another major accounting firm selected by the Company, which will provide detailed supporting calculations both to the Company and you within fifteen (15) business days after the date of the termination of your employment or such earlier time as is requested by the Company, and will be made at the expense of the Company. The fact that your right to payments or benefits may be reduced by reason of the limitations contained in this Section 16 will not of itself limit or otherwise affect any of your other rights under this Agreement. If any payment or benefit is required to be reduced pursuant to this Section 16 and no such payment or benefit qualifies as a “deferral of compensation” within the meaning of and subject to Section 409A of the Code (“Nonqualified Deferred Compensation”), you will be entitled to designate the payments and/or benefits to be so reduced in order to give effect to this Section 16. The Company will provide you with all information that you reasonably request to permit you to make such designation. If any payment or benefit is required to be reduced pursuant to this Section 16 and any such payment or benefit constitutes Nonqualified Deferred Compensation or you fail to elect an order in which payments or benefits will be reduced pursuant to this Section 16, then the reduction will occur in the following order: (a) the payments under Section 8(c)(iii) or 8(d)(C) as applicable, (b) the payments under Section 8(c)(vi) or 8(d)(F) as applicable, (c) any other cash payments to be made to you but only if the value of such cash payments is not greater than the parachute value of such payments, (d) other payments, including cancellation of acceleration of vesting, if applicable, ratably. Within any category of payments and benefits (that is, (a), (b), (c) or (d)), (i) a reduction will occur first with respect to amounts that are not Nonqualified Deferred Compensation within the meaning of Section 409A of the Code and then with respect to amounts that are, and (ii) the payment and/or benefit amounts to be reduced and the acceleration of vesting to be cancelled, if applicable, shall be reduced or cancelled in the inverse order of their originally scheduled dates of payment or vesting, as applicable.
17.Representations.
(a)You represent that, except as expressly set forth below, your employment under this Agreement will not violate any law or duty by which you are bound, and will not conflict with or violate any agreement or instrument (including any non-competition or non-solicitation covenants with any prior employer or any other entity) to which you are a party or by which you are bound.
(b)You acknowledge that (i) all cash and equity incentive awards granted to you by the Company or any of its Affiliates will be subject to the terms of such awards (as set forth
13



in this Agreement and the respective grant agreements) and will be subject to recapture under the Company’s Incentive-Based Compensation Clawback Policy and/or the Company’s Financial Restatement Recovery Policy, each as currently in effect and as may be amended from time to time and (ii) you will be subject to the Company’s stock ownership guidelines as currently in effect and as may be amended from time to time.
(c)You represent that you are legally authorized to work in the United States, and you will provide documentation showing such authorization to the Company on your Effective Date. You acknowledge that, in order for the Company to comply with United States law, the Company may not employ anyone who cannot provide documentation showing that they are legally authorized to work in the United States.
(d)You represent that during your employment with your prior employers: (i) you complied materially with all codes of conduct and policies of your prior employers, including those regarding nondiscrimination and harassment in the workplace, insider trading and improper payments, and all laws underlying such codes of conduct and policies (the “Standards”), and (ii) you were not disciplined for a violation of the Standards. In addition, you represent that you are not aware of any allegations against you claiming a violation of the Standards.
You represent that all information provided to the Company or its agents by you or your representatives with regard to your background, and all representations made by you to the Company or its agents in the hiring process, were and are true and correct to the best of your knowledge.
18.Miscellaneous.
(a)Governing Law. This Agreement will be governed by and construed in accordance with the laws of the State of Connecticut without reference to principles of conflict of laws.
(b)Entire Agreement/Amendments. This Agreement and the instruments contemplated herein contain the entire understanding of the parties with respect to the employment of you by the Company from and after the Effective Date and, from the Effective Date, supersede any prior written or oral agreements between the Company and you, other than the Ancillary Agreements and the Clawback Policy Acknowledgments which were executed by you in connection with this Agreement. In the event of any conflict in terms or provisions between this Agreement and the Ancillary Agreements, the terms and provisions of this Agreement will prevail and govern. There are no restrictions, agreements, promises, warranties, covenants, or undertakings between the parties with respect to the subject matter herein other than those expressly set forth or referred to herein and therein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto.
(c)No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion will not be considered a waiver of such party’s rights or
14



deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. Any such waiver must be in writing and signed by you or an authorized officer of the Company, as the case may be.
(d)Assignment. This Agreement will not be assignable by you. This Agreement will be assignable by the Company only to an acquirer of all or substantially all of the assets of the Company or other successor to the Company, provided such acquirer or successor promptly assumes all of the obligations hereunder of the Company in a writing delivered to you or otherwise complies with the provisions hereof with regard to such assumption.
(e)Successors; Binding Agreement; Third Party Beneficiaries. This Agreement will inure to the benefit of and be binding upon the personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, legatees, and permitted assignees of the parties hereto.
(f)Communications. For the purpose of this Agreement, notices and all other communications provided for in this Agreement will be in writing and be deemed to have been duly given (i) when delivered (including via electronic mail) or (ii) two (2) business days after being mailed by United States registered or certified mail, return receipt requested, postage prepaid, addressed to your latest address on file with the Company and the Company’s address at 800 Connecticut Avenue, Norwalk, Connecticut, 06854, Attn: General Counsel, as applicable, or to such other address as any party may have furnished to the other in writing in accordance herewith. Notice of change of address will be effective only upon receipt.
(g)Withholding Taxes. The Company may withhold from any and all amounts payable under this Agreement such Federal, state, and local taxes and other similar amount as may be required to be withheld pursuant to any applicable law or regulation. Notwithstanding any other provision of this Agreement, the Company shall not be obligated to guarantee any particular tax result for you with respect to any payment provided to you hereunder, and you will be responsible for any taxes imposed on you with respect to any such payment.
(h)Survivorship. The respective rights and obligations of the parties hereunder, including, without limitation, those in the Ancillary Agreements, will survive any termination of your employment to the extent necessary to the agreed preservation of such rights and obligations.
(i)Counterparts. This Agreement may be signed in counterparts (including via facsimile or other electronic transmission), each of which will be deemed an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
(j)Headings. The headings of the sections contained in this Agreement are for convenience only and will not be deemed to control or affect the meaning or construction of any provision of this Agreement.
15



(k)Section 409A of the Code. Each payment or reimbursement and the provision of each benefit under this Agreement will be considered a separate payment and not one of a series of payments for purposes of Section 409A of the Code. Furthermore, if any payment made under this Agreement is subject to payment during a specified time frame (e.g., within ninety (90) days of a termination of employment) as opposed to payment on a specific payment date (e.g., January 1, 2025), the Company, in its sole discretion, will determine the exact date upon which such payment will be made during the specified payment period. To the extent applicable, it is intended that this Agreement comply with or be exempt from the provisions of Section 409A of the Code so that the income inclusion provisions of Section 409A(a)(1) do not apply. This Agreement will be administered in a manner consistent with this intent. All reimbursements provided under this Agreement will be made or provided in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during your lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred, and (iv) the right to reimbursement is not subject to liquidation or exchange for another benefit. Reference to Section 409A of the Code includes any regulations, or any other formal guidance, promulgated with respect to such section by the U.S. Department of the Treasury or the Internal Revenue Service. Finally, if the period after the date of termination during which the Release must become effective spans two calendar years, any payments or benefits conditioned on the Release will not be made or commence to be made until the second calendar year.
19.Operation of Agreement. This Agreement will be binding immediately upon its execution, but, notwithstanding any provision of this Agreement to the contrary, this Agreement will not become effective or operative (and neither party will have any obligation hereunder) until the Effective Date.

*    *    *





If you agree with the foregoing, please sign and date this Agreement in the space indicated below.

Very truly yours,
BOOKING HOLDINGS INC.

/s/ Glenn D. Fogel     
16



Glenn D. Fogel
Chief Executive Officer and President
            
Accepted and agreed to:    

/s/ Ewout Steenbergen    
Ewout Steenbergen
Date: December 4, 2023
                    




Appendix A: Form of Release

Appendix B: Non-Competition and Non-Solicitation Agreement

Appendix C: Employee Confidentiality and Assignment Agreement

Appendix D: Incentive-Based Compensation Clawback Policy

Appendix E: Financial Restatement Recovery Policy

17

EX-99.3 3 exhibit993.htm EX-99.3 Document
    EXHIBIT 99.3
Booking Holdings Inc. 1999 Omnibus Plan
RESTRICTED STOCK UNIT AGREEMENT [ — NON-U.S. PARTICIPANTS]
THIS RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”) is made by and between Booking Holdings Inc., a Delaware corporation, with its principal United States office at 800 Connecticut Avenue, Norwalk, Connecticut 06854 (the “Company”), and the Participant, as of the Grant Date in ______, which is provided, along with additional grant details, on the web portal of the secure third-party vendor website (the “Web Portal”) used by the Company (such information to be referred to herein as the “Grant Summary”) for the administration of the Booking Holdings Inc. 1999 Omnibus Plan, as amended from time to time (the “Plan”). Pursuant to the terms of the Plan, the Compensation Committee of the Board (the “Committee”) has authorized this Agreement and approved the grant of restricted stock units (“RSUs”) evidenced hereby.
[For purposes of this Agreement, “Employer” means the Affiliate or Subsidiary of the Company that employs the Participant.] Unless otherwise indicated, any capitalized term used herein, but not defined herein, shall have the meaning ascribed to such term in the Plan.
1.The Grant
(a)    Subject to the terms and conditions set forth herein, the Participant has been granted on the Grant Date in ______ the number of RSUs as indicated on the Grant Summary for the corresponding Grant Date in ______.
(b)    Subject to Section 4 hereof, ______ of the RSUs evidenced by this Agreement shall vest on ______ (each a “Vesting Date”); provided that, on each Vesting Date, the Participant has been in Continuous Service through such date. For avoidance of doubt, subject to Section 4 hereof, the Participant shall not proportionately or partially vest in any RSUs during any period prior to each Vesting Date, and the Participant shall become vested in the RSUs only on the applicable Vesting Dates pursuant to this Section 1(b).
(c)    Upon satisfaction of the vesting requirements set forth in Section 1(b) and within ______ days following each such Vesting Date, the Company shall issue the Participant one (1) share of Stock free and clear of any restrictions for each vested RSU. [Notwithstanding the foregoing, the Company may, in its sole discretion, settle all or a portion of any vested RSUs in the form of a cash payment to the extent settlement in shares of Stock is prohibited under local laws, rules or regulations, would require the Participant, the Company or the Employer to obtain the approval of any governmental and/or regulatory body in the Participant’s country of residence (or country of employment, if different), or is administratively burdensome. Alternatively, the Company, in its sole discretion, may settle all or a portion of the vested RSUs in the form of shares of Stock but require an immediate sale of such shares of Stock (in which case, the Participant expressly and explicitly authorizes the Company to issue sales instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold the Participant’s shares of Stock).]
(d)    For purposes of this Agreement, “Continuous Service” shall mean that the Participant’s service with the Company or any Subsidiary or Affiliate, whether as an employee, director or consultant, is not interrupted or terminated.
2.Dividend Equivalents
        

        
        The Company shall credit the Participant, on an applicable Vesting Date, with an additional number of RSUs (rounded down to the nearest whole number) equal in value to any dividends that the Participant would have received after the Grant Date and prior to the applicable Vesting Date had the Participant been the actual owner of the number of shares of Stock represented by the RSUs.  The additional RSUs shall be subject to the same terms and conditions as reflected in this Agreement (and any related addendum, if applicable), including the vesting, settlement, and clawback/recoupment provisions applicable to the original RSUs.  Notwithstanding the foregoing, the Company may, in its discretion and in lieu of crediting the Participant with an additional number of RSUs for such dividend equivalents, provide such dividend equivalents in the form of a cash payment to the Participant (subject to any applicable withholding of Tax-Related Items).
3.No Voting Rights
The Participant shall not be a stockholder of record and shall have no voting or other stockholder rights with respect to shares of Stock underlying the RSUs evidenced by this Agreement prior to the dates on which shares of Stock are issued to the Participant pursuant to this Agreement.
4.Effect of Termination of Continuous Service
(a)Subject to Sections 4(b), (c) and (d), upon the Participant’s termination of Continuous Service for any reason, the unvested portion of the RSUs evidenced by this Agreement shall be immediately forfeited and cancelled.
(b)Notwithstanding Section 1(b) or 4(a), if, prior to a Vesting Date, the Participant’s Continuous Service is terminated by the Company for Cause, then the Participant shall forfeit any right to, and not be issued or receive, any shares of Stock under this Agreement.
(c)Notwithstanding Section 1(b) or 4(a), upon the date of a termination of Continuous Service by the Participant on account of death, the Participant’s designated beneficiary shall be fully vested in any RSUs that remain unvested as of such date. The Company shall issue the Participant’s designated beneficiary one (1) share of Stock free and clear of any restrictions for each RSU that vests pursuant to this Section 4(c) within ______ days following the date of the Participant’s death.
(d)Notwithstanding Section 1(b) or 4(a), upon the date of a termination of Continuous Service by (i) the Company other than for Cause, (ii) the Participant for Good Reason, or (iii) the Participant on account of Disability, the Participant shall be vested in a Pro-Rata Number of RSUs (inclusive of any RSUs that previously vested prior to such termination pursuant to Section 1(b) above), and any unvested RSUs shall be immediately forfeited and canceled. The Company shall issue the Participant one (1) share of Stock free and clear of any restrictions for each RSU that vests pursuant to this Section 4(d) (and that was not previously settled pursuant to Section 1(c) above) within ______ days following the date of termination of Continuous Service.
(e)A “Pro-Rata Number of RSUs” means a number of RSUs equal to [______], multiplied by a fraction, the numerator of which is the number of days that have elapsed during the period commencing on the Grant Date and ending on [the date of termination of Continuous Service][___anniversary of the Grant Date] and the denominator of which is ______].

2



        
(f)The determination of whether the Participant’s Continuous Service is terminated by the Company other than for Cause shall be made by the Committee (or any officer of the Company to whom the Committee has delegated this authority), in its sole discretion.
(g)[For purposes of this Agreement, if the Participant is a local national of and employed in a country that is a member of the European Union, the grant of the RSUs and the terms and conditions governing the RSUs are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the "Age Discrimination Rules"). To the extent a court or tribunal of competent jurisdiction determines that any provision of the RSUs is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.]
(h)For the purposes of Section 4, the following terms shall have the following meanings:
(i)“Cause” shall mean (A) the willful and continued failure by the Participant substantially to perform his or her duties and obligations to the Company (other than any such failure resulting from his or her incapacity due to physical or mental illness); (B) the willful engaging by the Participant in misconduct which is materially injurious to the Company; (C) the commission by the Participant of a felony; (D) the willful and material violation by the Participant of any Company code of conduct; (E) the commission by the Participant of a crime against the Company which is materially injurious to the Company; (F) a material breach by the Participant of any non-competition, non-solicitation, or other restrictive covenant that the Participant has entered into with the Company or a Subsidiary; or (G) the willful and material breach by the Participant of any confidentiality agreement that the Participant has entered into with the Company or a Subsidiary. For purposes of this Section 4(g)(i) [Section 4(h)(i)], no act, or failure to act, on a Participant’s part shall be considered “willful” unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that his or her action or omission was in the best interest of the Company.
(ii)“Disability” shall mean (A) any physical or mental condition that would qualify the Participant for a disability benefit under any long-term disability plan maintained by the Company and applicable to him or her; (B) if there is no such plan, such condition provided in any applicable governmental statute or regulation that constitutes a Disability; or (C) if there is no such applicable statute or regulation, such other condition as may be determined by the Committee in its sole discretion to constitute a Disability.
(iii)“Good Reason” shall mean the occurrence of any of the following without the Participant’s prior written consent: (A) a material diminution in the Participant’s authority, duties, title, reporting structure, or responsibilities; (B) a relocation of the Company’s (or, as applicable, an Affiliate’s or Subsidiary’s) principal office to a location more than ______miles from its current location or more than ______ miles further from the Participant’s residence at the time of such relocation (provided the Participant is required by the Company or, as applicable, an Affiliate or Subsidiary, to work regularly from such principal office location) or (C) any material breach by the Company of an employment agreement, if any, that is in effect at any time between the Participant and the Company.  
Before a termination by the Participant will constitute termination for Good Reason, the Participant must give the Company a Notice of Good Reason within ______ calendar days following the occurrence of the event that constitutes Good Reason. Failure to provide such
3



        
Notice of Good Reason within such ______-day period shall be conclusive proof that the Participant shall not have Good Reason to terminate employment by reason of such occurrence.
Good Reason shall exist only if (A) the Company fails to remedy the event or events constituting Good Reason within ______ calendar days after receipt of the Notice of Good Reason from the Participant and (B) the Participant terminates his or her employment within ______days after the end of the ______-day period set forth in clause (A) above.
(iv)“Notice of Good Reason” shall mean a written notice by the Participant to the Company which sets forth in reasonable detail the specific reason for a termination of employment for Good Reason and the facts and circumstances claimed to provide a basis for such termination and is provided to the Company in accordance with the terms set forth in Section 4(g)(iii) [Section 4(h)(iii)] hereof.
5.Nontransferability of Grant
Except as otherwise provided herein or in the Plan, the RSUs shall not be assigned, negotiated, pledged, or hypothecated in any way or be subject to execution, attachment or similar process. No transfer of the Participant’s rights with respect to the RSUs, whether voluntary or involuntary, by operation of law or otherwise, shall be permitted. Immediately upon any attempt to transfer such rights, such RSUs, and all of the rights related thereto, shall be forfeited by the Participant.
6.Stock; Adjustment Upon Certain Events
(a)Stock to be issued under this Agreement, if any, shall be made available, at the discretion of the Board or the Committee, either from authorized but unissued Stock or from Stock reacquired by the Company in the open market, in private transactions or otherwise.
(b)The existence of this Agreement and the RSUs evidenced hereunder shall not affect in any way the right or power of the Board or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, any merger or consolidation of the Company or any affiliate, any issue of bonds, debentures, preferred or prior preference stocks ahead of or affecting the Stock, the authorization or issuance of additional shares of Stock, the dissolution or liquidation of the Company or any affiliate or sale or transfer of all or part of the assets or business of the Company or any affiliate, or any other corporate act or proceeding.
(c)Upon a Change in Control, the purchaser(s) of the Company’s assets or stock or the surviving entity in a merger or consolidation may, in his, her or its discretion, deliver to the Participant the same kind of consideration that is delivered to the stockholders of the Company as a result of such Change in Control, or the Board may cancel all outstanding RSUs in exchange for consideration in cash or in kind, which consideration in both cases shall be determined by the Board.
7.Determinations
Each determination, interpretation or other action made or taken pursuant to the provisions of this Agreement by the Committee or the Board (or by any officer of the Company to whom authority has been delegated by the Committee or the Board) in good faith shall be final, conclusive and binding for all purposes and upon all persons, including, without limitation,
4



        
the Participant and the Company, and their respective heirs, executors, administrators, personal representatives and other successors in interest.
8.Other Conditions
The transfer of any shares of Stock underlying the RSUs shall be effective only at such time as counsel to the Company shall have determined that the issuance and delivery of such shares are in compliance with all applicable laws, regulations of governmental authority and the requirements of any securities exchange on which the shares of Stock are traded.
9.Withholding Taxes
(a)Regardless of any action the Company or the employer [Employer] takes with respect to any or all federal, state, local or foreign income tax, social insurance, payroll tax, payment on account or other tax related-items (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax Related-Items associated with the RSUs is the Participant’s responsibility and that the Company and the employer [Employer] (i) make no representations or undertakings regarding the treatment of any Tax Related-Items in connection with any aspect of the RSUs, including, but not limited to, the grant or vesting of the RSUs, the delivery of shares of Stock, the subsequent sale of shares of Stock acquired at vesting and the receipt of any dividends or dividend equivalents; and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant’s liability for Tax Related-Items. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the employer [Employer] (or former employer, as applicable) may be required to withhold or account for Tax Related-Items in more than one jurisdiction.
(b)If the Participant’s country of residence (and/or the country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold any shares of Stock otherwise issuable upon vesting that have an aggregate Fair Market Value sufficient to pay the minimum Tax-Related Items required to be withheld [(or an equivalent cash amount, where the RSUs are settled in cash in the Company's sole discretion)]. For purposes of the foregoing, no fractional shares of Stock will be withheld or issued pursuant to the grant of the RSUs. If the obligation for Tax-Related Items is satisfied by withholding shares of Stock [or a portion of the cash proceeds (where the RSUs are settled in cash in the Company's sole discretion)], for tax purposes, the Participant shall be deemed to have been issued the full number of shares of Stock [(or the gross amount of the cash payment)], notwithstanding that a number of shares of Stock [(or a portion of cash proceeds)] are withheld solely for the purpose of satisfying any withholding obligations for the Tax-Related Items due as a result of any aspect of the Participant’s participation in the Plan. In addition, where the RSUs are settled in shares of Stock, the Company may, on behalf of the Participant, sell a sufficient number of whole shares of Stock issued upon vesting of the RSUs having an aggregate Fair Market Value that would satisfy the withholding amount. Alternatively, the Company or the employer [Employer] may, in its discretion and subject to applicable law, withhold any amount necessary to pay the Tax-Related Items from the Participant’s regular salary/wages or other amounts payable to the Participant, with no withholding of shares of Stock [or cash proceeds] payable upon vesting, or may require the Participant to submit payment equivalent to the minimum Tax-Related Items required to be withheld by means of certified check, cashier’s check or wire transfer. In the event the withholding requirements for Tax-Related Items are not satisfied through one of the foregoing methods, no shares of Stock will be released to the Participant (or the Participant’s estate) upon vesting of the RSUs [(or no cash payment will be made where the RSUs are settled in cash in the Company's sole discretion)] unless and until satisfactory arrangements (as determined by the Company in its sole discretion) have been made by the Participant with respect to the payment of
5



        
any such Tax-Related Items. By accepting the RSUs, the Participant expressly consents to the withholding methods for Tax-Related Items as provided hereunder and/or any other methods of withholding that the Company or the employer [Employer] may take and are permitted under the Plan to meet the withholding and/or other requirements as provided under applicable laws, rules and regulations. All Tax-Related Items related to the RSUs shall be the sole responsibility of the Participant.
(c)Notwithstanding the foregoing, the following provision shall apply if the Participant is subject to Section 16 of the Securities Exchange Act of 1934 as of the date the relevant RSU first becomes includible in the gross income of the Participant for purposes of Tax Related-Items. All Tax Related-Items legally payable by the Participant in respect of the RSUs shall be satisfied by the Company, withholding a number of the shares of Stock that would otherwise be delivered to the Participant upon the vesting or settlement of the RSUs with a Fair Market Value, determined as of the date of the relevant taxable event, equal to the minimum statutory withholding amount that applies to the Participant, rounded up to the nearest whole share (“Net Settlement”). The Net Settlement mechanism described herein was approved by the Committee prior to the Grant Date in a manner intended to constitute “approval in advance” by the Committee for purposes of Rule 16b3-(e) under the Securities Exchange Act of 1934, as amended.
(d)If the obligation for Tax Related-Items is satisfied by Net Settlement, for tax purposes, the Participant shall be deemed to have been issued the full number of shares of Stock issued upon vesting of the RSUs notwithstanding that a number of the shares of Stock are held back solely for the purpose of paying the Tax Related-Items.
10.[Data Privacy
The Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data by and among, as applicable, the Company and its Subsidiaries and Affiliates for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan. The Participant hereby understands that the Company and its Subsidiaries and Affiliates hold (but only process or transfer to the extent required or permitted by local law) the following personal information about the Participant: the Participant’s name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all RSUs or any other entitlement to shares of Stock awarded, canceled, purchased, exercised, vested, unvested or outstanding in the Participant’s favor, for the purpose of implementing, administering and managing the Plan (“Data”). The Participant hereby understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including Certent, Inc., American Stock Transfer & Trust Company, LLC, and E*TRADE, that these recipients may be located in the Participant’s country or elsewhere (such as the United States of America), and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant hereby understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any shares acquired upon vesting of the RSUs. The Participant hereby understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan and in accordance with local law. The Participant hereby understands
6



        
that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local human resources representative. The Participant hereby understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant hereby understands that the Participant may contact the Participant’s local human resources representative.]
11.Incorporation of the Plan
        The Plan, as it exists on the date of this Agreement and as amended from time to time, is hereby incorporated by reference and made a part hereof, and the RSUs and this Agreement shall be subject to all terms and conditions of the Plan. In the event of any conflict between the provisions of this Agreement and the provisions of the Plan, the terms of the Plan shall control, except as expressly stated otherwise.
12.Electronic Delivery
        The Company may, in its sole discretion, deliver any documents related to the RSUs and the Participant’s participation in the Plan, or future awards that may be granted under the Plan, by electronic means or request the Participant’s consent to participate in the Plan by electronic means, to the extent permitted by applicable law. The Participant hereby consents to receive such documents by electronic delivery and, if requested, agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
13.Nature of Grant
The Participant acknowledges and agrees that: (a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan; (b) the grant of RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past; (c) all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company; (d) participation in the Plan is voluntary; (e) the RSUs are not a part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, holiday pay, pension or retirement benefits or welfare or similar payments; (f) the future value of the underlying shares is unknown, indeterminable and cannot be predicted with certainty; and (g) in consideration of the grant of RSUs, no claim or entitlement to compensation or damages shall arise from termination of the RSUs or diminution in value of the RSUs or shares received upon vesting including (without limitation) any claim or entitlement resulting from termination of the Participant’s active employment by the Company or a Subsidiary or Affiliate (for any reason whatsoever and whether or not in breach of local labor laws) and the Participant hereby releases the Company and its Subsidiaries and Affiliates from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by signing this Agreement, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such claim.
14.Section 409A of the Code
7



        
        To the extent applicable, it is intended that this Agreement and the Plan comply with, or be exempt from, the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Participant. This Agreement and the Plan shall be administered in a manner consistent with this intent. References to Section 409A of the Code are to Section 409A of the Internal Revenue Code of 1986, as amended, and will also include any regulations, or any other formal guidance, promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.
15.Miscellaneous
(a)Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, personal legal representatives, successors, trustees, administrators, distributees, devisees and legatees. The Company shall assign this Agreement to any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, and will require such successor to expressly assume and agree in writing to perform this Agreement. Notwithstanding the foregoing, this Agreement may not be assigned by the Participant.
(b)Amendments. Any amendment to the Plan will be deemed to be an amendment to this Agreement to the extent that the amendment is applicable to this Agreement. Furthermore, no modification or waiver of any of the provisions of this Agreement that would reduce the Participant’s rights under this Agreement shall be effective unless memorialized in writing and consented to by the party against whom it is sought to be enforced.
(c)Waiver. The failure of any party hereto at any time to require performance by another party of any provision of this Agreement shall not affect the right of such party to require performance of that provision, and any waiver by any party of any breach of any provision of this Agreement shall not be construed as a waiver of any continuing or succeeding breach of such provision, a waiver of the provision itself, or a waiver of any right under this Agreement.
(d)Headings. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall in no way restrict or modify any of the terms or provisions hereof.
(e)Fees and Compliance with Law. The Company shall pay all fees and expenses necessarily incurred by the Company in connection with this Agreement and will from time to time use its reasonable efforts to comply with all laws and regulations which, in the opinion of counsel to the Company, are applicable thereto.
(f)Notices. All notices, consents, requests, approvals, instructions and other communications provided for herein shall be in writing and validly given or made when delivered (including via email, the Web Portal or other electronic means), or on the second succeeding business day after being mailed by registered or certified mail, whichever is earlier, to the persons entitled or required to receive the same, at the addresses set forth at the heading of this Agreement or to such other address as either party may designate by like notice. Notices by the Participant under, pursuant to, or in connection with, this Agreement shall be addressed to the Company’s principal office, attention of the Company’s General Counsel.
(g)Complete Agreement. The Plan, this Agreement and the Grant Summary constitute the entire agreement and understanding between the parties with respect to the matters described herein and supersede all prior and contemporaneous agreements and understandings, oral and written, between the parties with respect to such subject matter.
8



        
(h)Governing Law; Choice of Law. This Agreement shall be governed and construed and the legal relationships of the parties determined in accordance with the laws of the state of Delaware without reference to principles of conflict of laws. Further, for purposes of litigating any dispute that arises directly or indirectly between the parties regarding the RSUs evidenced by this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction and venue of the federal or state courts of the state of Delaware of the United States of America, and agree that such litigation shall be conducted exclusively in such courts.
(i)Authorization. The Company represents and warrants that it is duly authorized by its Board and/or the Committee (and by any other person or body whose authorization is required) to enter into this Agreement, that there is no agreement or other legal restriction which would prevent it from entering into, and carrying out its obligations under, this Agreement, and that the officer signing this Agreement is duly authorized and empowered to sign this Agreement on behalf of the Company.
(j)Investigations. Notwithstanding anything in this Agreement or any other agreement with the Company or a Subsidiary, nothing shall limit the Participant’s rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity.
(k)Severability. In the event that one or more of the provisions of this Agreement is invalidated for any reason by a court of competent jurisdiction, any provision so invalidated will be deemed to be separable from the other provisions of this Agreement, and the remaining provisions of this Agreement will continue to be valid and fully enforceable.
(l)[Language. By accepting the Agreement, the Participant acknowledges and represents that the Participant is sufficiently proficient in the English language, or has consulted with an advisor who is sufficiently proficient in English, so as to allow the Participant to understand the terms of the Agreement and any other documents related to the Plan. If the Participant has received a copy of this Agreement (or the Plan or any other document related hereto or thereto) translated into a language other than English, such translated copy is qualified in its entirety by reference to the English version of the Plan, and in the event of any conflict the English version will govern.]
16.[Non-U.S. Addendum
Notwithstanding any provisions in this Agreement, the RSUs shall also be subject to the additional terms and conditions set forth in the Non-U.S. Addendum attached as Appendix A to this Agreement for the Participant’s country. Moreover, if the Participant relocates to one of the countries included in the Non-U.S. Addendum, the additional terms and conditions for such country will apply to the Participant to the extent the Company determines that the application of such terms and conditions are necessary or advisable in order to comply with local law or facilitate the administration of the Plan. The Non-U.S. Addendum attached hereto as Appendix A constitutes part of this Agreement.]
17.Imposition of Other Requirements
The Company reserves the right to impose other requirements on the RSUs, any payment made pursuant to the RSUs, and the Participant’s participation in the Plan, to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the RSUs and the Plan. Such requirements may include (but are not limited
9



        
to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.
18.Insider Trading/Market Abuse Laws
By accepting the RSUs, the Participant acknowledges that the Participant is bound by all the terms and conditions of any Company insider trading policy as may be in effect from time to time. The Participant further acknowledges that, depending on the Participant’s country of residence (and country of employment, if different), the Participant may be or may become subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of shares of Stock, rights to shares of Stock (e.g., RSUs) or rights linked to the value of shares of Stock under the Plan during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before the Participant possessed inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party, which may include fellow employees and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any Company insider trading policy as may be in effect from time to time. The Participant acknowledges that it is the Participant’s personal responsibility to comply with any applicable restrictions, and the Participant should consult with the Participant’s personal legal and investment advisors for additional information.
19.[Legal and Tax Compliance; Cooperation
If the Participant resides or is employed outside of the United States, the Participant agrees, as a condition of the grant of the RSUs, to repatriate all payments attributable to the shares of Stock and/or cash acquired under the Plan (including, but not limited to, dividends and any proceeds derived from the sale of shares of Stock acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in the Participant’s country of residence (and country of employment, if different). In addition, the Participant also agrees to take any and all actions, and consents to any and all actions taken by the Company and its Affiliates and Subsidiaries, as may be required to allow the Company and its Affiliates and Subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence (and country of employment, if different).]
20.No Advice Regarding Grant
No employee of the Company is permitted to advise the Participant on whether the Participant should acquire shares of Stock under the Plan or provide the Participant with any legal, tax or financial advice with respect to the grant of the RSUs. Investment in shares of Stock involves a degree of risk. Before deciding to acquire shares of Stock pursuant to the RSUs, the Participant should carefully consider all risk factors and tax considerations relevant to the acquisition of shares of Stock under the Plan or the disposition of them. Further, the Participant should carefully review all of the materials related to the RSUs and the Plan, and the Participant should consult with the Participant’s personal legal, tax and financial advisors for professional advice in relation to the Participant’s personal circumstances.
21.[Foreign Asset/Account Reporting Requirements and Exchange Controls
10



        
The Participant’s country of residence (and country of employment, if different) may have certain foreign asset/account reporting requirements and exchange controls which may affect the Participant’s ability to acquire or hold shares of Stock under the Plan or cash received from participating in the Plan (including any dividends paid on shares of Stock, sale proceeds resulting from the sale of shares of Stock acquired under the Plan) in a brokerage or bank account outside the Participant’s country of residence (and country of employment, if different). The Participant may be required to report such accounts, assets, or transactions to the tax or other authorities in the Participant’s country of residence (and country of employment, if different). The Participant may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country of residence (and country of employment, if different) through a designated bank or broker within a certain time after receipt. The Participant acknowledges that it is the Participant’s personal responsibility to be compliant with such regulations and the Participant should consult with the Participant’s personal legal advisor for additional information.]
11



        
IN WITNESS WHEREOF, this Agreement has been executed by the Company as of the Grant Date as set forth on the Grant Summary.
BOOKING HOLDINGS INC.
[Name]
[Title]


12



        
[Appendix A
NON-U.S. ADDENDUM
Additional Terms and Conditions for Equity Grants Under the
Booking Holdings Inc. 1999 Omnibus Plan (as amended and restated as of June 3, 2021)
[Date]
Terms and Conditions
This Non-U.S. Addendum includes additional terms and conditions that govern the restricted stock units (“RSUs”) granted to the Participant under the Booking Holdings Inc. 1999 Omnibus Plan (amended and restated as of June 3, 2021) (referred to as the “Plan”) if the Participant resides in one of the countries listed below. Certain capitalized terms used but not defined in this Non-U.S. Addendum have the meanings set forth in the Plan and/or the Participant's award agreement (the “Agreement”) that relates to the Participant's award. By accepting the Participant's award, the Participant agrees to be bound by the terms and conditions contained in the paragraphs below in addition to the terms of the Plan, the Agreement, and the terms of any other document that may apply to the Participant and the Participant's award.
Notifications
This Non-U.S. Addendum also includes information regarding securities, exchange control and other issues of which the Participant should be aware with respect to participation in the Plan. The information is based on the securities, exchange control, and other laws in effect in the respective countries as of [Date]. Such laws are often complex and change frequently. As a result, it is strongly recommended that the Participant not rely on the information in this Non-U.S. Addendum as the only source of information relating to the consequences of the Participant's participation in the Plan because the information may be out of date at the time the Participant vest in the Participant's RSUs or sell shares acquired under the Plan.
In addition, the information contained herein is general in nature and may not apply to the Participant's particular situation, and Booking Holdings Inc. (the “Company”) is not in a position to assure the Participant of a particular result. Accordingly, the Participant is advised to seek appropriate professional advice as to how the relevant laws in the Participant's country may apply to the Participant's situation.
Finally, if the Participant is a citizen or resident of a country other than the one in which the Participant is currently working, transferred employment after the RSUs were granted to the Participant, or are considered a resident of another country for local law purposes, the information contained herein may not apply.
COUNTRY-SPECIFIC PROVISIONS
NETHERLANDS
Terms and Conditions
13



        
Investigations. Section 15(j) of the Agreement is hereby amended in its entirety to read as follows:
“(j)    Investigations.     Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement prevents the Participant, in accordance with applicable law, from the internal or external reporting, or public disclosure, of possible legal violations. Within the framework of applicable law, these acts include reporting to authorities without prior notice to the Company or any Subsidiary that employs the Participant, or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations. For purposes of clarity, the Participant is not prohibited from providing information voluntarily to the Securities and Exchange Commission pursuant to Section 21F of the Exchange Act.”

Notifications
Insider-Trading Notification. The Participant should be aware of the Dutch insider-trading rules, which may impact the sale of shares of Stock acquired upon vesting of the RSUs. In particular, the Participant may be prohibited from effectuating certain transactions involving shares of Stock if the Participant has inside information about the Company. If the Participant is uncertain whether the insider-trading rules apply to them, the Participant should consult the Participant's personal legal advisor. By accepting the grant of RSUs and participating in the Plan, the Participant acknowledges having read and understood this notification and acknowledge that it is the Participant's responsibility to comply with the Dutch insider-trading rules.
GDPR. Please consult the notice addressing the EU General Data Protection Regulation, which is attached hereto as Addendum A and which replaces Section 10 of the Agreement.]


14


EX-99.4 4 exhibit994.htm EX-99.4 Document
EXHIBIT 99.4


Non-Competition and Non-Solicitation Agreement
    This Non-Competition and Non-Solicitation Agreement (the “Agreement”) is dated December 1, 2023 by and between Booking Holdings Inc., a Delaware corporation, and Ewout Steenbergen (the “Employee”).

    The parties, intending to be legally bound, agree as follows:

1.ACKNOWLEDGEMENTS
    (a)    The Employee acknowledges that the Company (as defined below) has expended and shall continue to expend substantial amounts of time, money and effort to develop business strategies, employee and customer relationships and goodwill, and to build an effective organization. The Employee acknowledges that the Company has a legitimate business interest in protecting such efforts. The Employee also acknowledges and agrees that in the performance of the duties and responsibilities of employment, the Employee has and will become familiar with the Company’s confidential information, including trade secrets, and that the Employee’s services are of special, unique and extraordinary value to the Company. Further, the Employee acknowledges that the Company would be seriously and irreparably damaged by the disclosure of trade secrets, confidential information and/or the loss or deterioration of its business strategies, employee and customer relationships and goodwill. The Employee further understands and agrees that the foregoing makes it necessary for the protection of the business and the Company that the Employee not compete with the Company during his employment and for a reasonable period thereafter, as further provided in the following Paragraphs.

    For purposes of this Agreement:

        (i)    “Affiliate” means, with respect to any specified person or entity, any other person or entity that directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is under common Control with, such specified person or entity;

        (ii)    “Company” means Booking Holdings Inc. as well as all direct and indirect subsidiaries and Affiliates of Booking Holdings Inc.; and

        (iii)    “Control” (including, with correlative meanings, the terms “Controlled by” and “under common Control with”), as used with respect to any person or entity, means the direct or indirect power to direct or cause the direction of the management or policies of such person or entity, whether through the ownership of voting securities, by contract or otherwise.

    (b)    The Employee acknowledges (i) that the business of the Company is global in scope and without geographical limitation and (ii) notwithstanding the jurisdiction of formation or principal office of the Company or any of its respective executives or employees (including, without limitation, the Employee), it is expected that the Company will have business activities and valuable business relationships within its industry throughout the world. In addition, the Employee agrees and acknowledges that the potential harm to the Company of the non-enforcement of the provisions of this Agreement outweighs any potential harm to the Employee of its enforcement by injunction or otherwise.

    (c)    The Employee acknowledges that the Employee (i) has carefully read this Agreement, fully understands the restraints imposed upon the Employee by this Agreement, and voluntarily agrees to its terms and conditions; (ii) was not coerced to sign this Agreement and was not under duress at the time the Employee signed this Agreement; (iii) by signing this Agreement, the Employee will not violate the terms of any other agreement previously entered by the Employee; and (iv) prior to signing this Agreement, the Employee had adequate time to consider entering into this Agreement, including, without limitation, the opportunity to discuss the terms and conditions of this Agreement, as well as its legal consequences with an attorney of their choice. The Employee expressly acknowledges and agrees that, especially given the nature and scope of the Company’s business, each and every restraint imposed by this Agreement is reasonable with respect to subject matter, time period and geographical area.




2.NON-COMPETITION AND NON-SOLICITATION
    (a)    The Employee will not, while an employee of the Company, and for a period of one year following the termination of his employment for any reason (the “Restriction Period”), directly or indirectly, without the prior written consent of the Company:

        (i)    (A)    engage in any of the same or substantially similar activities, duties, or responsibilities that the Employee had while an employee of the Company, for any other company or business that competes with the Company; provided, however, that the restriction in this Section 2(a)(i)(A) shall not apply where (1) the Employee’s employment is terminated by the Company without Cause or by the Employee for Good Reason, in either case within the Employee’s first six months of employment with the Company, and (2) the Employee executes a Release on or after his date of termination which becomes effective within 55 days after such date of termination (where “Cause,” “Good Reason” and “Release” have the meanings set forth in the Employment Agreement between the Employee and the Company dated December 1, 2023);

            (B)    solicit or attempt to solicit any customer or client, or actively sought prospective customer or client, of the Company, to purchase any travel related goods or services of the type sold by the Company from anyone other than the Company; or

            (C)    assist any person or entity in any way to do, or attempt to do, anything prohibited by (A) or (B) above; or

        (ii)    (A)    solicit, recruit or hire to work for the Employee or any organization with which the Employee is connected, any employees of the Company or any persons who, within one (1) year of such solicitation, recruitment or hire, have worked for the Company;

            (B)    solicit or encourage any employee of the Company to leave the services of the Company; and

            (C)    intentionally interfere with the relationship of the Company with any person who is employed by or otherwise engaged to perform services for the Company; provided, that neither (I) the general advertisement for employees or the general solicitation of employees by a recruiter, nor (II) the Employee’s being named as an employment reference for a current or former employee of the Company and responding to ordinary course inquiries made of the Employee by prospective employers of such employee in connection with such reference, shall be deemed a violation of this clause (ii).

The Restriction Period shall be tolled during (and shall be deemed automatically extended by) any period in which the Employee is in violation of the provisions of this Section 2.

    (b)    Notwithstanding anything to the contrary contained in this Agreement, the foregoing covenant will not be deemed breached as a result of the Employee’s passive ownership of less than an aggregate of 2% of any class of securities of any entity listed on a U.S. national securities exchange.

(c)    If any provision or clause of this Agreement, or portion thereof, is held by any court or other tribunal of competent jurisdiction to be illegal, invalid, unreasonable, or otherwise unenforceable against the Employee, the remainder of such provision shall not be thereby affected and will be deemed to be modified to the minimum extent necessary to remain in force and effect for the longest period and largest geographic area that would not constitute such an unreasonable or unenforceable restriction. It is the express intention of the parties that, if any court or other tribunal of competent jurisdiction construes any provision or clause of this Agreement, or portion thereof, is held by any court or other tribunal of competent jurisdiction to be illegal, invalid, unreasonable, or otherwise unenforceable against the Employee because of the duration of such provision, the scope of the subject matter, or the geographic area covered thereby, such court or tribunal shall reduce the duration, scope, or area of such provision, and, in its reduced form, such provision shall then be enforceable and be enforced. Moreover, notwithstanding the fact that any provision of this Section 2 is determined not to be enforceable in equity, if such provision is enforceable at law, the Company will be entitled to recover monetary damages as a result of the Employee’s breach of such provision.




3.NONDISCLOSURE AGREEMENT
    Simultaneously with entering into this Agreement, the Employee will enter into the Company’s Employee Confidentiality and Assignment Agreement.

4.NONDISPARAGEMENT
Subject to Section 7, while an employee of the Company, and for the one-year period following cessation of the Employee’s employment with the Company for any reason, the Employee shall not publicly, or in a manner that is intended to become public, make any statements, written (including electronic statements, such as via X (formerly known as Twitter), Facebook or other social media) or oral, which disparage or defame the goodwill or reputation of the Company, or its directors or senior officers.

5.NOTIFICATION OF SUBSEQUENT EMPLOYER
    The Employee hereby agrees that prior to accepting employment with any other person or entity during any period during which the Employee remains subject to any of the covenants set forth in Section 2, the Employee shall provide such prospective employer with written notice of such provisions of this Agreement, with a copy of such notice delivered simultaneously to the Company.

6.REMEDIES AND INJUNCTIVE RELIEF
    The Employee acknowledges that a violation by the Employee of any of the covenants contained in Section 2, 3 or 4 would cause irreparable damage to the Company in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, the Employee agrees that, notwithstanding any provision of this Agreement to the contrary, the Company shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and/or permanent injunctions) in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in Section 2, 3 or 4 in addition to any other legal or equitable remedies it may have. The preceding sentence shall not be construed as a waiver of the rights that the Company may have for damages under this Agreement or otherwise, and all of the Company’s rights shall be unrestricted.

7.PERMITTED DISCLOSURES
Nothing in the Agreement, or any other policy or agreement by or with the Company shall prohibit or restrict the Employee from (a) voluntarily communicating with an attorney retained by the Employee, (b) voluntarily communicating with any law enforcement, government agency, including the Security and Exchange Commission (“SEC”), the Equal Employment Opportunity Commission, state or local commission on human rights, or any self-regulatory organization or public body regarding possible violations of law, in each case without advance notice to the Company, or otherwise initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by such government agency, (c) recovering a SEC whistleblower award as provided under Section 21F of the Securities Exchange Act of 1934, or (d) disclosing any confidential information to a court or other administrative or legislative body in response to a subpoena, provided that the Employee first promptly notify and provides the Company with the opportunity to seek, and join in its efforts at the sole expense of the Company, to challenge the subpoena or obtain a protective order limiting its disclosure, or other appropriate remedy.

8.CONSIDERATION
     This Agreement is entered into in consideration of the Employee’s employment by the Company in a position where Employee will be provided and have access to the Company’s confidential information, including trade secrets, which information is constantly evolving and expanding.

9.MISCELLANEOUS
    (a)    Notices. All notices, consents, waivers, and other communications under this Agreement must be in writing and will be deemed given to a party when (i) delivered to the appropriate address by



hand or by nationally recognized overnight courier service (costs prepaid, with written confirmation of receipt); (ii) sent by facsimile with written confirmation of transmission by the transmitting equipment, provided that a copy is sent by certified mail, return receipt requested; or (iii) received or rejected by the addressee, if sent by certified mail, return receipt requested; in each case to the following addresses or facsimile numbers and marked to the attention of the individual (by name or title) designated below:
        
        (i)    if to the Company, to:
Booking Holdings Inc.
800 Connecticut Avenue
Norwalk, CT 06854
            Attention: General Counsel

            Fax #: 203-299-8915

(ii)    if to the Employee, to the Employee’s address on the books and records of the Company from time to time

or such other addresses as the parties may have furnished to each other pursuant to the provisions of this Section.
    (b)    Entire Agreement and Modification. This Agreement supersedes all prior agreements between the parties with respect to its subject matter, and constitutes a complete and exclusive statement of the terms of the agreement between the parties with respect to its subject matter. This Agreement may not be amended, supplemented or otherwise modified except by a written agreement executed by the parties.

    (c)    Construction. In this Agreement, the word “including” indicates examples of a foregoing general statement and not a limitation on that general statement. No provision of this Agreement will be interpreted for or against any party because that party or its legal representative drafted the provision.

    (d)    Assignments. The Company may assign this Agreement, or any of its rights and duties hereunder, without the Employee’s consent, to any subsidiary or Affiliate of the Company or to any person or entity which acquires all, or substantially all, of the assets or business of the Company or any of the Company’s divisions, businesses or subsidiaries. This Agreement is personal to the Employee and may not be assigned or delegated by the Employee without the prior written consent of the Company, and any such attempted assignment or delegation shall be void. Subject to the foregoing, this Agreement will apply to, be binding in all respects upon, and inure to the benefit of the Employee’s heirs, executors, and administrators and the Company’s successors and assigns.

    (e)    Waiver. The parties’ rights hereunder are cumulative and not alternative. Neither the failure nor any delay by any party in exercising any right, power, or privilege hereunder will operate as a waiver of such right, power, or privilege. No single or partial exercise of any such right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege. To the maximum extent permitted by applicable law: (i) no claim or right arising out of this Agreement can be discharged by a party, in whole or in part, by a waiver or renunciation of the claim or right by the other party, unless in writing signed by such other party; (ii) no waiver that may be given by a party will be applicable except in the specific instance(s) for which it is given and only to the extent expressly set forth in writing and signed by such party; and (iii) no notice to or demand on one party will be deemed to be a waiver of any obligation of such party or of the right of the party giving such notice or demand to take further action without notice or demand as provided herein. The Employee will not assert that the Company’s failure, refusal to enforce, or delay in enforcing any agreement containing obligations identical or similar to those contained in this Agreement against any



of its other employees or former employees constitutes, and the Employee agrees that it does not constitute, a waiver of the Company’s rights hereunder.

    (f)    Governing Law; Jurisdiction; Service of Process. This Agreement will be governed by and construed under the laws of Connecticut without regard to conflicts of laws principles that would require the application of any other law. Any action or proceeding arising out of or relating to this Agreement may be brought in the courts of the State of Connecticut, County of Fairfield; or, if there is a basis for jurisdiction, such actions may be brought in the United States District Court for Connecticut. Each of the parties irrevocably submits to the jurisdiction of such courts in any such action or proceeding and waives any objection it may now or hereafter have to venue or convenience of forum. Process in any action or proceeding referred to in the preceding sentence may be served on any party anywhere in the world.

    (g)    Counterparts. This Agreement may be executed in one or more counterparts.

The parties have executed this Agreement on the date first written above.

                Booking Holdings Inc.


By: /s/ Glenn D. Fogel_________________________
Name:    Glenn D. Fogel
Title:     Chief Executive Officer and President


EMPLOYEE


                    /s/ Ewout Steenbergen                    
                     Ewout Steenbergen

EX-99.5 5 exhibit995.htm EX-99.5 Document




EXHIBIT 99.5

EMPLOYEE CONFIDENTIALITY AND ASSIGNMENT AGREEMENT
Booking Holdings Inc. (“Company”), having a business at 800 Connecticut Avenue, Norwalk, Connecticut 06854, and its parents, affiliates, subsidiaries, related and acquired companies (hereinafter collectively with the Company referred to as the “Company Entities”), develops, purchases, and uses valuable Confidential Information and Inventions (as hereinafter defined). It is vital to the current and anticipated business interests of the Company Entities that all such Confidential Information be maintained in strict confidence and remain proprietary to the Company Entities. It is also vital that Inventions made by employees of the Company Entities be properly protected and that legitimate interests of the Company Entities in such Inventions be preserved.

I am currently, or desire to become, employed by the Company or another Company Entity in a capacity in which I will receive or develop, or otherwise handle or be exposed to, Confidential Information. In consideration of my becoming employed by a Company Entity, or my continuing to be employed by a Company Entity (all such employment being at will and subject to any other ancillary agreement(s) which may be in effect), and the payment to me of a salary and/or other compensation during my employment, I agree, irrespective of any changes in the scope or nature of my employment (or my ceasing to be employed by any Company Entity as follows:

1.Confidential Information

1.1.As used herein, “Confidential Information” means private, confidential, trade secret or other proprietary information (whether or not embodied or contained in some tangible form) relating to any actual or anticipated business of the Company Entities or any research and development of the Company Entities, or information suggested by or resulting from any tasks assigned to me or work performed by me for or on behalf of the Company Entities and information, observations and data concerning the business or affairs of the Company Entities, including, without limitation, all business information which relates to the Company Entities, or their customers, suppliers or contractors or any other third parties in respect of which the Company Entities has a business relationship or owes a duty of confidentiality, or their respective businesses or products, and which is not known to the public generally other than as a result of my breach of this Agreement. Confidential Information includes, but is not limited to, any information which, if kept secret, will provide one or more of the Company Entities an actual or potential economic advantage over others in the relevant trade or industry, such as, but not limited to: technical information or reports, trade secrets, operating instructions, training materials, formulae, compilations, computer programs and files, devices, methods, techniques, discoveries, software codes, unwritten information and know-how, Inventions, research and development, business data (including cost data), designs, strategies, processes, methods, prospects, plans and opportunities, customer lists, customer buying records and habits, marketing and sales strategies, marketing plans, marketing surveys, profitability analyses, specifications, financial information, invention disclosures, unpublished or pending patent applications (whether abandoned or not), products, product
1





cost, product sales records and documents, product development, long-range plans, information relating to pricing, competitive strategies and new product development, services, research, information relating to any forms of compensation or other personnel-related information, contracts and supplier lists. For purposes of this Agreement, Confidential Information shall also include any information or material received in confidence by a Company from a third party, and/or information held in confidence by a third party and made available to me through the sharing of space, administrative support or other resources by the Company Entities. Confidential Information will not include (i) such information known to me prior to my involvement with the Company Entities (including contact information contained in my personal rolodex or electronic address book), or (ii) such information that was lawfully received by me from a third party without breach of any confidential obligation to any of the Company Entities.

Except as required in performing my duties to a Company Entity or with the prior written authorization of the Company, during the term of my employment and thereafter, I will not directly or indirectly use, disclose, disseminate or otherwise reveal any Confidential Information unless and only to the extent such Confidential Information becomes generally available to the public through no act or fault of mine. In the event that I am required by a court of law to disclose Confidential Information, I shall first (where practical) provide the Company with notice of any such order so it may seek a protective order against disclosure by a court of competent jurisdiction (and I will use my reasonable best efforts in cooperating with the Company to obtain such protective order). Notwithstanding anything to the contrary in this Agreement or any other agreement with any Company Entity, nothing shall limit my rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity. Notwithstanding the foregoing, I agree to waive my right to recover monetary damages in connection with any charge, complaint or lawsuit filed by me or anyone else on my behalf (whether involving a governmental entity or not); provided that I am not agreeing to waive, and this Agreement shall not be read as requiring me to waive, any right I may have to receive an award for information provided to any governmental entity.

1.2.During my employment with any Company Entity, I will not use, disclose or induce any Company Entity to use any Inventions, proprietary or confidential information or trade secrets of any former employer or other person or entity which I have an obligation to keep in confidence. Further, I will not bring onto any Company Entity’s premises or transfer onto any Company Entity technology systems any Inventions, confidential or proprietary information or trade secrets belonging to any such third party unless disclosure to, and use by, the Company or any of the Company Entities has been consented to in writing by such third party.

1.3     I represent and warrant to the Company that I am under no obligation (such as a non-competition agreement) to a former employer or any other party
2





affecting my ability: (a) to perform the terms of this Agreement; (b) to be employed by the Company or any other Company Entity; or (c) to otherwise perform services to any Company Entity.

2.Inventions

2.1.As used herein, “Inventions” means inventions, discoveries, concepts, works and ideas, whether or not patentable, copyrightable, trademarkable, protectable as a mask work, or protectable as a trade secret, including, but not limited to, any process, method, formula, article, composition, device, product, tool, machine, computer program, software (including source code and object code), apparatus, appliance, design, drawing, practice, manufacture or technique, as well as any improvements thereto and know- how related thereto.

2.2.I hereby agree to the following obligations concerning Inventions without payment to me of any royalty or further consideration therefor:

2.2.1.With respect to Inventions made or conceived by me (either solely or jointly with another or others), whether or not during my hours of employment or whether or not I actually used facilities, materials or personnel of the Company Entities, for the duration of my employment by any Company Entity and for one (1) year thereafter, so long as such invention (a) is based on or related to Confidential Information, or (b) relates to any past, present or anticipated business of a Company Entity, or (c) results from any actual work performed by me for a Company Entity (“Company Invention(s)”):

2.2.1.1.I shall promptly and fully inform the Company of each such Company Invention in writing, setting forth in detail the procedures employed and the results achieved;

2.2.1.2.I hereby agree to and hereby do assign to the Company or such other person as the Company shall designate all of my rights, title and interest in each such Company Invention, including but not limited to applications for United States and/or foreign patents, and United States and/or foreign patents granted upon such Invention; and

2.2.1.3.I acknowledge that all original works of authorship arising from Inventions created by me in the course of my employment shall be considered works made for hire under the United States Copyright Act and that these works shall, upon their creation, be owned exclusively by the respective Company Entity. To the extent that any of these works may not be considered works made for hire under applicable law, I hereby assign to the Company Entity by which I am employed or its designee the ownership of all copyright rights in such works.
3






2.2.2.With respect to such Company Inventions, at any time during and in perpetuity after my employment with any Company Entity:

2.2.2.1.I shall apply, at such Company Entity’s request or at the request of such other entity as the Company shall direct and expense, for United States and foreign patents or copyrights or other form of protection either in my name or otherwise as the Company shall desire. To the extent that I am unable or unavailable or shall unreasonably refuse to sign any lawful or necessary document required in order for the applicable Company Entity (or its designee) to apply for and obtain a patent or copyright registration with respect to any work performed by me, I hereby irrevocably designate and appoint the applicable Company Entity (or its designee) and its duly authorized officers and agents as my agent and attorney-in- fact to act for and on my behalf to execute and file any such applications, and to do all other lawfully permitted acts to further the prosecution and issuance of patents with the same legal force and effect as if executed by me; and

2.2.2.2.I shall acknowledge and deliver promptly to the applicable Company Entity (or its designee), without charge such written instruments, and do such other acts, such as giving testimony in support of my inventorship, authorship or contribution, as may be reasonably necessary in the opinion of the applicable Company Entity (or its designee) to obtain and maintain United States and/or foreign patents or copyright or other protection and to vest the entire right and title of same in such Company Entity (or its designee).

2.3.To the extent an assignment or transfer of the rights in Section 2.2 is invalid or unenforceable, the Company Entities shall have a perpetual, irrevocable, worldwide, fully-paid, royalty-free right and license to use, disclose, make, distribute, copy, modify, exploit and sell products, processes, and/or services derived from any Inventions, which are conceived or made by me during the hours which I am employed by any Company Entity or with the use or assistance of the facilities, materials or personnel of one or more of the Company Entities.

2.4.I acknowledge and represent that except as disclosed in Section 3 below, there are no Inventions that were made by me, acquired by me, or are otherwise owned by me (in whole or in part) as of the date of this Agreement (“Prior Inventions”). I will not, to the best of my knowledge, use, rely on, or incorporate any preexisting confidential information and/or Prior Inventions without first informing the Company Entity by which I am employed in writing and receiving such Company Entity’s advance written
4





permission to do so. I acknowledge and agree that if I use any of the Prior Inventions in the scope of my employment, I hereby grant and the Company Entities a perpetual, irrevocable, worldwide, fully-paid, royalty-free right and license to use, disclose, make, distribute, copy, modify, exploit the Prior Inventions and sell products, processes, and/or services derived from any Prior Inventions.

3.Excluded from my obligations under Section 2 above are the following Prior Inventions:

I cannot assign such Prior Inventions to the Company or any other Company Entity or any Company Entity’s designee because of prior agreements with the following individuals or entities:
.
4.The following identifies all Prior Inventions prior to my employment with any Company Entity in which I have any title or interest:
.
5.Upon termination of my employment with any Company Entity (for any reason), or at any time as the Company Entity may request, I will promptly deliver or return to such Company Entity all documents (whether prepared by a Company Entity, me, or a third party) relating to the Company Entities, or any of their businesses or property and any other tangible property of the Company Entities, in each case which I may possess or have under my direction or control, including, without limitation, all documents, records, notebooks, data, reports, notes, compilations, computer files, data and programs, equipment, parts and tools and similar repositories or materials and any and all copies thereof; provided, however, I do not need to deliver or return documents provided to me in my capacity as a participant in any employee benefit plan, policy, or program of a Company Entity or any agreement by and between me and a Company Entity with regard to my employment or severance.

6.I acknowledge that I am hereby notified that the immunity provisions of Section 1833 of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (i) in confidence to federal, state or local governmental officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (iii) to my attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is not disclosed except pursuant to court order. Nothing in the Agreement, or any other policy or agreement by or with the Company shall prohibit or restrict me from (a) voluntarily communicating with an attorney retained by me, (b) voluntarily communicating with any law enforcement, government agency, including the Security and Exchange Commission ("SEC"), the Equal Employment Opportunity Commission, state or local commission on human rights, or any self-regulatory organization or public body regarding possible
5





violations of law, in each case without advance notice to the Company, or otherwise initiating, testifying, assisting, complying with a subpoena from, or participating in any manner with an investigation conducted by such government agency, (c) recovering a SEC whistleblower award as provided under Section 21F of the Securities Exchange Act of 1934, or (d) disclosing any confidential information to a court or other administrative or legislative body in response to a subpoena, provided that I first promptly notify and provide the Company with the opportunity to seek, and join in its efforts at the sole expense of the Company, to challenge the subpoena or obtain a protective order limiting its disclosure, or other appropriate remedy.

7.I understand and agree that the terms of this Agreement are reasonable and necessary to protect the Company Entities’ respective business interests. I further agree that the Company Entities would suffer irreparable losses if I violate the terms of this Agreement and that money damages may not be an adequate remedy. Thus, in addition to any other rights or remedies, all of which shall be deemed cumulative, the Company Entities and each of them shall be entitled to obtain injunctive relief to enforce the terms of this Agreement. It is hereby acknowledged that the provisions of this Agreement are for the benefit of the Company Entities and each such Company Entity may enforce the provisions of this Agreement and only the applicable Company Entity can waive the rights hereunder with respect to its Confidential Information and employees.

8.All my obligations under this Agreement shall be binding upon my heirs, assigns, and legal representatives.

9.The Company shall have the right to assign this Agreement to another Company Entity or to a successor to all or substantially all of the business or assets of the Company or of any division or part of the Company or any Company Entity.

10.This Agreement is in addition to and does not supersede or replace any existing agreement, written or otherwise, entered into between or among me and any Company Entity relating to the subject matter hereof, provided that in the event of any conflict between this Agreement and any other such agreement, this Agreement shall control. No amendment, waiver or modification of this Agreement shall be valid unless in writing and signed by both me and a duly authorized representative of the Company.

11.This Agreement shall be construed and enforced under the internal laws of the State of Connecticut.

12.In the event that any provision of this Agreement shall be held invalid or unenforceable by reason of the scope or duration thereof or for any other reason, such invalidity or unenforceability shall attach only to the particular aspect of such provision found invalid or unenforceable and shall not affect any other any other provision of this Agreement. To the fullest extent permitted by law, this Agreement shall be construed as if the scope or duration of such provision had been more narrowly drafted so as not to be invalid or unenforceable.

6





13.I acknowledge receipt of a copy of this Agreement.



Ewout Steenbergen            /s/ Ewout Steenbergen             12/4/2023
Employee's Full Name (printed)    Employee's Signature    Date



7
EX-99.6 6 exhibit996.htm EX-99.6 Document
EXHIBIT 99.6
Booking Holdings Announces New Executive Vice President and Chief Financial Officer

NORWALK, Conn., 13 December, 2023 – Booking Holdings Inc. (NASDAQ: BKNG) announced today that Ewout Steenbergen will join the company as Executive Vice President and Chief Financial Officer effective March 15, 2024. Mr. Steenbergen joins Booking Holdings from S&P Global, where he most recently served as Executive Vice President and Chief Financial Officer. Mr. Steenbergen will lead Booking Holdings’ worldwide finance organization, which includes Finance, Tax, Treasury, Accounting, Internal Audit, Corporate Development, Real Estate and Investor Relations. He will report directly to Glenn Fogel, Chief Executive Officer, and succeeds David Goulden, who announced his retirement as Chief Financial Officer earlier this year after six years with the company.

“Ewout’s deep experience in technology and finance will be an asset to our company as we look to achieve our vision for the future of travel,” said Mr. Fogel. “With his extensive global leadership experience and track record of delivering value to stakeholders, I look forward to working with Ewout to further fuel long-term growth at Booking Holdings and our brands. I would also like to extend my profound gratitude to David Goulden for his impeccable leadership during his six years as CFO at the company. He has been instrumental in driving numerous strategic and transformative initiatives and contributing immeasurably to our company’s achievements in that time. I am pleased that we’ll continue to benefit from his ongoing active involvement with Booking Holdings.”

As CFO at S&P Global, Mr. Steenbergen was responsible for all aspects of the Finance department, focused on growth and sustainable shareholder value, as well as for the S&P Global Engineering Solutions Division (until its divestiture earlier this year) and Kensho Technologies. Prior to joining S&P, he was Executive Vice President and CFO of Voya Financial, Inc. and served in other leadership roles at ING Group around the globe.

“Booking Holdings sits at the epicenter of digital travel innovation, and I am pleased to be joining the company at such an exciting time for the industry and its stakeholders,” said Mr. Steenbergen. “I look forward to working alongside the company’s strong leadership team to continue the company’s growth, capitalize on the long-term opportunities in front of us, and achieve our strategic objectives.”

Mr. Steenbergen holds a master's degree in Actuarial Science from the University of Amsterdam and a master's degree in Business Administration from the University of Rochester and from Nyenrode University. He also serves as Chair of the Board of Directors of UNICEF USA.

Source: Booking Holdings
#BKNG_Corporate

About Booking Holdings Inc.
Booking Holdings (NASDAQ: BKNG) is the world’s leading provider of online travel and related services, provided to consumers and local partners in more than 220 countries and territories through six primary consumer facing brands: Booking.com, Priceline, Agoda, Rentalcars.com, KAYAK and OpenTable. The mission of Booking Holdings is to make it easier for everyone to experience the world. For more information, visit BookingHoldings.com and follow us on X (formerly known as Twitter) @BookingHoldings.


EX-101.SCH 7 bkng-20231213.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 8 bkng-20231213_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 bkng-20231213_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 4.500% Senior Notes Due 2031 4.50% Senior Notes Due 2031 [Member] 4.50% Senior Notes Due 2031 Entity Information [Line Items] Entity Information [Line Items] 4.250% Senior Notes Due 2029 4.250% Senior Notes Due 2029 [Member] 4.250% Senior Notes Due 2029 Document Period End Date Document Period End Date Common Stock par value $0.008 per share Common Stock [Member] Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code 4.750% Senior Notes Due 2034 4.750% Senior Notes Due 2034 [Member] 4.750% Senior Notes Due 2034 Entity Central Index Key Entity Central Index Key 0.500% Senior Notes Due 2028 0.5% Senior Notes Due March 2028 [Member] 0.5% Senior Notes Due March 2028 4.125% Senior Notes Due 2033 4.125% Senior Notes Due 2033 [Member] 4.125% Senior Notes Due 2033 2.375% Senior Notes Due 2024 2.375% Senior Notes Due September 2024 [Member] [Member] 2.375% Senior Notes Due September 2024 [Member] [Member] Entity Address, City or Town Entity Address, City or Town 4.000% Senior Notes Due 2026 4.000% Senior Notes Due 2026 [Member] 4.000% Senior Notes Due 2026 Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 0.100% Senior Notes Due 2025 0.100% Senior Notes Due 2025 [Member] 0.100% Senior Notes Due 2025 Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer 1.800% Senior Notes Due 2027 1.8% Senior Notes Due March 2027 [Member] 1.8% Senior Notes Due March 2027 [Member] Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company 3.625% Senior Notes Due 2028 3.625% Senior Notes due 2028 [Member] 3.625% Senior Notes due 2028 Document Type Document Type Amendment Flag Amendment Flag Class of Stock [Axis] Class of Stock [Axis] Entity File Number Entity File Number Entities [Table] Entities [Table] Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 10 bkng-20231213_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Dec. 13, 2023
Entity Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 13, 2023
Entity Registrant Name Booking Holdings Inc.
Entity Central Index Key 0001075531
Entity Incorporation, State or Country Code DE
Entity File Number 1-36691
Entity Tax Identification Number 06-1528493
Entity Address, Address Line One 800 Connecticut Avenue
Entity Address, City or Town Norwalk
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06854
City Area Code 203
Local Phone Number 299-8000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock par value $0.008 per share  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock par value $0.008 per share
Trading Symbol BKNG
Security Exchange Name NASDAQ
2.375% Senior Notes Due 2024  
Entity Information [Line Items]  
Title of 12(b) Security 2.375% Senior Notes Due 2024
Trading Symbol BKNG 24
Security Exchange Name NASDAQ
0.100% Senior Notes Due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.100% Senior Notes Due 2025
Trading Symbol BKNG 25
Security Exchange Name NASDAQ
4.000% Senior Notes Due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 4.000% Senior Notes Due 2026
Trading Symbol BKNG 26
Security Exchange Name NASDAQ
1.800% Senior Notes Due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.800% Senior Notes Due 2027
Trading Symbol BKNG 27
Security Exchange Name NASDAQ
0.500% Senior Notes Due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.500% Senior Notes Due 2028
Trading Symbol BKNG 28
Security Exchange Name NASDAQ
3.625% Senior Notes Due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.625% Senior Notes Due 2028
Trading Symbol BKNG 28A
Security Exchange Name NASDAQ
4.250% Senior Notes Due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 4.250% Senior Notes Due 2029
Trading Symbol BKNG 29
Security Exchange Name NASDAQ
4.500% Senior Notes Due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 4.500% Senior Notes Due 2031
Trading Symbol BKNG 31
Security Exchange Name NASDAQ
4.125% Senior Notes Due 2033  
Entity Information [Line Items]  
Title of 12(b) Security 4.125% Senior Notes Due 2033
Trading Symbol BKNG 33
Security Exchange Name NASDAQ
4.750% Senior Notes Due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 4.750% Senior Notes Due 2034
Trading Symbol BKNG 34
Security Exchange Name NASDAQ
XML 12 bkng-20231213_htm.xml IDEA: XBRL DOCUMENT 0001075531 2023-12-13 2023-12-13 0001075531 us-gaap:CommonStockMember 2023-12-13 2023-12-13 0001075531 bkng:A2.375SeniorNotesDueSeptember2024MemberMember 2023-12-13 2023-12-13 0001075531 bkng:A0100SeniorNotesDue2025Member 2023-12-13 2023-12-13 0001075531 bkng:A4000SeniorNotesDue2026Member 2023-12-13 2023-12-13 0001075531 bkng:A1.8SeniorNotesDueMarch2027Member 2023-12-13 2023-12-13 0001075531 bkng:A05SeniorNotesDueMarch2028Member 2023-12-13 2023-12-13 0001075531 bkng:A3625SeniorNotesDue2028Member 2023-12-13 2023-12-13 0001075531 bkng:A4250SeniorNotesDue2029Member 2023-12-13 2023-12-13 0001075531 bkng:A450SeniorNotesDue2031Member 2023-12-13 2023-12-13 0001075531 bkng:A4125SeniorNotesDue2033Member 2023-12-13 2023-12-13 0001075531 bkng:A4750SeniorNotesDue2034Member 2023-12-13 2023-12-13 false 0001075531 8-K 2023-12-13 Booking Holdings Inc. DE 1-36691 06-1528493 800 Connecticut Avenue Norwalk CT 06854 203 299-8000 false false false false Common Stock par value $0.008 per share BKNG NASDAQ 2.375% Senior Notes Due 2024 BKNG 24 NASDAQ 0.100% Senior Notes Due 2025 BKNG 25 NASDAQ 4.000% Senior Notes Due 2026 BKNG 26 NASDAQ 1.800% Senior Notes Due 2027 BKNG 27 NASDAQ 0.500% Senior Notes Due 2028 BKNG 28 NASDAQ 3.625% Senior Notes Due 2028 BKNG 28A NASDAQ 4.250% Senior Notes Due 2029 BKNG 29 NASDAQ 4.500% Senior Notes Due 2031 BKNG 31 NASDAQ 4.125% Senior Notes Due 2033 BKNG 33 NASDAQ 4.750% Senior Notes Due 2034 BKNG 34 NASDAQ false EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 12 22 1 false 11 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Sheet http://www.bookingholdings.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bkng-20231213.htm bkng-20231213.xsd bkng-20231213_def.xml bkng-20231213_lab.xml bkng-20231213_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bkng-20231213.htm": { "nsprefix": "bkng", "nsuri": "http://www.bookingholdings.com/20231213", "dts": { "inline": { "local": [ "bkng-20231213.htm" ] }, "schema": { "local": [ "bkng-20231213.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "bkng-20231213_def.xml" ] }, "labelLink": { "local": [ "bkng-20231213_lab.xml" ] }, "presentationLink": { "local": [ "bkng-20231213_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 10, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 12, "entityCount": 1, "segmentCount": 11, "elementCount": 38, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 52 }, "report": { "R1": { "role": "http://www.bookingholdings.com/role/DocumentandEntityInformation", "longName": "0000001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "bkng-20231213.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "bkng-20231213.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "bkng_A1.8SeniorNotesDueMarch2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A1.8SeniorNotesDueMarch2027Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "1.800% Senior Notes Due 2027", "label": "1.8% Senior Notes Due March 2027 [Member]", "documentation": "1.8% Senior Notes Due March 2027 [Member]" } } }, "auth_ref": [] }, "bkng_A450SeniorNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A450SeniorNotesDue2031Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "4.500% Senior Notes Due 2031", "label": "4.50% Senior Notes Due 2031 [Member]", "documentation": "4.50% Senior Notes Due 2031" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "bkng_A4250SeniorNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A4250SeniorNotesDue2029Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "4.250% Senior Notes Due 2029", "label": "4.250% Senior Notes Due 2029 [Member]", "documentation": "4.250% Senior Notes Due 2029" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "bkng_A4000SeniorNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A4000SeniorNotesDue2026Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "4.000% Senior Notes Due 2026", "label": "4.000% Senior Notes Due 2026 [Member]", "documentation": "4.000% Senior Notes Due 2026" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "bkng_A2.375SeniorNotesDueSeptember2024MemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A2.375SeniorNotesDueSeptember2024MemberMember", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "2.375% Senior Notes Due 2024", "label": "2.375% Senior Notes Due September 2024 [Member] [Member]", "documentation": "2.375% Senior Notes Due September 2024 [Member] [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock par value $0.008 per share", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "bkng_A3625SeniorNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A3625SeniorNotesDue2028Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "3.625% Senior Notes Due 2028", "label": "3.625% Senior Notes due 2028 [Member]", "documentation": "3.625% Senior Notes due 2028" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "bkng_A4750SeniorNotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A4750SeniorNotesDue2034Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "4.750% Senior Notes Due 2034", "label": "4.750% Senior Notes Due 2034 [Member]", "documentation": "4.750% Senior Notes Due 2034" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "bkng_A05SeniorNotesDueMarch2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A05SeniorNotesDueMarch2028Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.500% Senior Notes Due 2028", "label": "0.5% Senior Notes Due March 2028 [Member]", "documentation": "0.5% Senior Notes Due March 2028" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "bkng_A0100SeniorNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A0100SeniorNotesDue2025Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "0.100% Senior Notes Due 2025", "label": "0.100% Senior Notes Due 2025 [Member]", "documentation": "0.100% Senior Notes Due 2025" } } }, "auth_ref": [] }, "bkng_A4125SeniorNotesDue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.bookingholdings.com/20231213", "localname": "A4125SeniorNotesDue2033Member", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "4.125% Senior Notes Due 2033", "label": "4.125% Senior Notes Due 2033 [Member]", "documentation": "4.125% Senior Notes Due 2033" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.bookingholdings.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 19 0001075531-23-000065-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001075531-23-000065-xbrl.zip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end